fluorodeoxyglucose f18 has been researched along with Carcinoma, Anaplastic in 557 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.18) | 18.7374 |
| 1990's | 20 (3.59) | 18.2507 |
| 2000's | 178 (31.96) | 29.6817 |
| 2010's | 300 (53.86) | 24.3611 |
| 2020's | 58 (10.41) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Chen, X; Fu, Z; Li, Q | 1 |
| Gao, C; Liu, H; Zou, Q | 1 |
| Kumar, S; Parmar, KM; Singh, P; Thummala, Y | 1 |
| Karanth, SS; Khanna, G; Malik, D; Manda, D; Raina, V; Sen, IB | 1 |
| Huang, R; Huang, S; Qi, Z; Su, M | 1 |
| Gong, W; Zhang, C; Zhang, G; Zhang, J; Zhang, W | 1 |
| Gambhir, S; Hassan, A; Ora, M; Saini, VK; Singh, AK | 1 |
| Atilgan, HI; Yalcin, H | 1 |
| Jie, X; Shi, H; Xiu, Y; Xu, A | 1 |
| Chae, Y; Kang, BT; Kim, H; Koo, Y; Ku, D; Lee, D; Son, M; Yang, MP; Yun, T | 1 |
| Aoyama, A; Hamakawa, H; Hara, S; Sato, Y; Shishido, Y; Takahashi, Y; Tomii, K | 1 |
| Fatima, N; Zaman, MU | 1 |
| Du, B; Jing, S; Li, X; Li, Y; Wang, S | 1 |
| Lin, R; Sun, Z; Tian, A; Yu, J; Yuan, X; Zhang, F; Zheng, Q; Zhong, Z | 1 |
| Bakshi, N; Chand, V; Duggal, R; Sangal, R | 1 |
| Li, G; Li, L; Li, Y; Xiao, L | 1 |
| Hu, F; Lan, X; Li, M; Zhang, X | 1 |
| Dai, N; Deng, S; Sang, S; Yang, Y | 1 |
| Ganesan, P; Goyal, H; Halanaik, D; Kishore, S | 1 |
| Agüloğlu, N; Aksu, A; Akyol, M; Unat, DS | 1 |
| Choudhury, S; Dwivedi, P; Jha, AK; Rangarajan, V; Sawant, V; Vajarkar, V; Vatsa, R | 1 |
| Asakage, T; Kawabe, H; Tateishi, U; Tsuchiya, J; Yokoyama, K | 1 |
| Atiyah, A; Benveniste, MF; Betancourt Cuellar, SL; Erasmus, JJ; Hofstetter, WL; Nguyen, QN; Truong, M | 1 |
| Ahn, MJ; Choi, JY; Han, J; Im, Y; Kim, J; Kwon, OJ; Park, YJ; Um, SW | 1 |
| Baykal Koca, S; Çermik, TF; Ergül, N; Sevindir, İ; Tatar, G | 1 |
| Arıöz Habibi, H; Yılmaz, S | 1 |
| Aro, K; Atula, T; Ilmarinen, T; Markkola, A; Schildt, J; Sistonen, HJ | 1 |
| Honma, K; Otsuka, I | 1 |
| Basu, S; Chakraborty, S; Chakravarty, R; Kalshetty, A; Nazar, AK | 1 |
| Chen, T; Fan, J; Li, W | 1 |
| Cai, J; Chen, H; Pang, Y; Xu, W; Zhao, L | 1 |
| Hijikata, Y; Hosono, M; Kanagaki, M; Takahashi, M; Umehana, M | 1 |
| M V, M; Manda, D; Shukla, V; Suresh, A | 1 |
| Lyburn, I; Nawwar, A; Robinson, E; Searle, J | 1 |
| Djikic Rom, A; Djuric-Stefanovic, A; Ivanovic, N; Jankovic, A; Kostadinovic, M; Kovac, JD; Mitrovic-Jovanovic, M; Odalovic, S; Plavsic, A; Simic, A; Skrobic, O | 1 |
| Chan, SC; Cheng, NM; Hsieh, CH; Liao, CT; Ng, SH; Wong, CK; Yen, TC | 1 |
| Li, L; Su, M; Wang, Y | 1 |
| George, T; Joshi, PV; Joshi, S; Kulkarni, M; Sahasrabudhe, S; Shewalkar, B | 1 |
| Azevedo, ÍM; Macedo, R; Medeiros, AC; Oliveira, CN; Rocha, KBF | 1 |
| Avci, N; Sengoz, T | 1 |
| Aksoy, T; Arslan, E; Çermik, TF; Dursun, N; Gürsu, RU; Sevinç, MM | 1 |
| Agrawal, A; Bakshi, G; M V, M; Menon, S; Prakash, G; Purandare, N; Puranik, A; Rangarajan, V; Shah, S | 1 |
| Aggarwal, A; Goel, S; Gupta, M; Iqbal, A; Rao, A; Singh, S | 1 |
| Ahmad, W; Gill, SM; Hassan, A | 1 |
| Liu, L; Piao, M; Tian, S; Wen, W; Xu, D; Xuan, D | 1 |
| Annunziata, A; Attanasio, L; Bombace, C; Cuocolo, A; Del Vecchio, S; Mainolfi, CG; Maurea, S; Petretta, M | 1 |
| Bendifallah, S; Body, G; Bricou, A; Collinet, P; Delvallée, J; Huchon, C; Lavoue, V; Ouldamer, L; Rossard, L; Touboul, C | 1 |
| Greenberg, DD | 1 |
| Asakage, T; Kawabe, H; Manabe, O; Oyama, J; Tateishi, U; Tateishi, Y; Tsuchiya, J; Yamamoto, K; Yokoyama, K | 1 |
| Chen, H; Guo, W | 1 |
| Dang, H; Huang, X; Liu, H; Ning, J; Wu, Y; Xu, B | 1 |
| Han, J; Li, F; Li, X; Li, Y; Qu, L | 1 |
| Araujo-Filho, JAB; Chang, J; Ginsberg, MS; Lobaugh, S; Mayoral, M; Perez-Johnston, R; Plodkowski, AJ; Rekhtman, N; Rusch, VW; Zheng, J | 1 |
| Girgin, RB; Gungor, S | 1 |
| Ahlström, H; Bergman, A; Jónsdóttir, B; Poromaa, IS; Ripoll, MA; Silins, I; Stålberg, K | 1 |
| Dabiri, BE; Jacene, HA | 1 |
| Colandrea, M; Di Stasio, GD; Ferrari, ME; Galetta, D; Grana, CM; Maisonneuve, P; Sorbello, S; Spaggiari, L; Travaini, L; Travascio, L | 1 |
| Chen, X; Wang, S; Wang, X; Wei, M; Yang, Z | 1 |
| Aher, PY; Graham, MM; Maheshwarappa, RP; Mishra, P; Ora, M; Priya, S; Soni, N | 1 |
| Baloğlu, MC; Beyhan, E; Çermik, TF; Erol, Ö; Şahin, R | 1 |
| Hamano, T; Hattori, K; Inoue, S; Kobayashi, Y; Otsuki, Y; Sasaki, K; Suzuki, K; Uebayashi, A; Yamamoto, H | 1 |
| Feng, M; He, Q; Huang, Y; Jiang, Q; Lang, J; Xu, P; Yin, J | 1 |
| Ishimori, T; Kanao, S; Miyake, KK; Nakamoto, Y; Nishimatsu, K; Togashi, K; Toi, M | 1 |
| Han, YQ; He, Q; Hu, Y; Li, Y; Liu, F; Liu, L; Luo, L; Ma, HZ; Mo, Y; Wang, H; Xi, XP; Xiao, F; Xiao, Q; Zhang, L | 1 |
| Baretton, G; Baumann, M; Bütof, R; Hofheinz, F; Jentsch, C; Kotzerke, J; Krause, M; Löck, S; Schmollack, J; Weitz, J; Zöphel, K; Zschaeck, S | 1 |
| Choe, YH; Jeong, JS; Kim, CH; Kim, SR; Lee, YC; Park, HS | 1 |
| Cheng, ZB; Jin, YN; Ma, J; Mo, HY; Sun, Y; Wang, SY; Yao, JJ; Zhang, F; Zhang, WJ; Zhou, GQ | 1 |
| Bove, S; Collarino, A; Evangelista, MT; Fragomeni, SM; Garganese, G; Gentileschi, S; Giordano, A; Ieria, FP; Perotti, G; Rufini, V; Scambia, G; Zagaria, L | 1 |
| Aktas, B; Forsting, M; Grueneisen, J; Herrmann, K; Kirchner, J; Ruhlmann, V; Sarabhai, T; Schaarschmidt, BM; Umutlu, L; Wetter, A | 1 |
| Chen, H; Chen, Y; He, S; Hong, S; Liang, S; Peng, P; Wang, Y; Xia, L; Yang, L | 1 |
| Goody, R; Marshall, K; McDermott, G; Murray, P; Prestwich, R; Radhakrishna, G; Scarsbrook, A; Ward, G | 1 |
| Valente, MA | 1 |
| Jeong, JS; Kim, CH; Kim, SR; Lee, YC | 1 |
| Chen, L; Guo, R; Guo, Y; Li, WF; Lin, XP; Liu, LZ; Ma, J; Mao, YP; Peng, H; Sun, Y; Tang, LL; Tian, L; Zhang, X; Zhang, Y | 1 |
| D'Amico, D; Fonti, R; Salvatore, B | 1 |
| Cheng, J; Ou, X; Ye, Y | 1 |
| Chen, W; Feng, Q; Jiang, J; Lu, L; Lv, W; Ma, J; Rahmim, A; Wang, Q; Yang, W; Yuan, Q | 1 |
| Alexander, EK; Angell, TE; Barletta, JA; Cho, NL; Cibas, ES; Doherty, GM; Gawande, AA; Howitt, BE; Krane, JF; Marqusee, E; Moore, FD; Nehs, MA; Strickland, KC; Vyas, CM | 1 |
| Ladrón de Guevara, D; Pardo, C; Pefaur, R; Quera, R; Reyes, JM; Rozas, S; Schacher, S | 1 |
| Bal, A; Kumar, R; Mittal, BR; Parihar, AS; Singh, H; Sinha, SK; Vadi, SK | 1 |
| Cho, H; Choi, EC; Kim, H; Kim, SH; Koh, YW; Yun, M | 1 |
| Avram, AM; Beesley, LJ; Bellile, EL; Manohar, PM; Worden, FP | 1 |
| Chen, XY; Luo, QY; Zhang, GQ; Zhang, XY | 1 |
| Date, H; Hamaji, M; Koyasu, S; Yamaguchi, K | 1 |
| Agrafiotis, AC; Constantinou, M; Hountis, P; Kanakakis, K; Kapranou, A; Moraitis, SD | 1 |
| Cheng, NM; Chou, WC; Chou, YC; Hsieh, CE; Liao, CT; Lin, CY; Venkatesulu, BP; Yen, TC | 1 |
| Caicedo-Granados, E; Cayci, Z; Gencturk, M; Li, F; Ozturk, K | 1 |
| de Bree, R; Hoekstra, OS; Pruim, J; van der Laan, BFAM; van der Putten, L; van Dijk, BAC; Wedman, J | 1 |
| He, Q; Zhang, B; Zhang, L; Zhang, X | 1 |
| Chen, D; Hsieh, MP; Nemer, JS; OʼToole, KM; Yeh, R | 1 |
| Hong-Zan, S; Jun, X; Li-Ou, Z; Qi-Yong, G; Xiao-Xi, B; Zai-Ming, L; Zhong-Wei, C | 1 |
| Agarwal, JP; Dholam, KP; Mahajan, A; Singh, GP | 1 |
| Chen, X; Fu, Z; Li, Q; Yang, X | 1 |
| Dematons, M; Flaus, A; Granjon, D; Longo, MG; Prevot, N | 1 |
| Borzì, G; Frasca, F; Gullo, D; Ilenia, M; Malandrino, P; Russo, M | 1 |
| Cheng, NM; Chou, WC; Fang, YD; Hsieh, CE; Liao, CT; Lin, CY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Croteau, E; Levasseur, MA; Marcotte, ME; Panet, F; Pavic, M; Richard, MA | 1 |
| Gilhuijs, KG; Koolen, BB; Pengel, KE; Rodenhuis, S; Rutgers, EJ; Valdés Olmos, RA; Vincent, AD; Vogel, WV; Vrancken Peeters, MJ; Wesseling, J | 1 |
| Jeon, YK; Kim, BH; Kim, IJ; Kim, SJ; Kim, SS; Kim, YK; Lee, CH | 1 |
| Hu, JW; Li, Y; Qi, L; Yang, ZQ; Ye, H | 1 |
| Bongiovanni, M; Ceriani, L; Franscella, S; Giovanella, L; Paone, G; Treglia, G | 1 |
| Cabral, FC; Jagannathan, JP; Kim, KW; Krajewski, KM; Ramaiya, NH | 1 |
| Chacón López-Muñiz, I; Espinosa Aunión, R; García Vicente, AM; González Ageitos, A; León Martín, A; Muñoz Madero, V; Muñoz Sánchez, Mdel M; Palomar Muñoz, A; Soriano Castrejón, Á | 1 |
| Alberini, JL; Bellet, D; Champion, L; Cherel, P; Edeline, V; Giraudet, AL; Lerebours, F; Wartski, M | 1 |
| Bae, JS; Baek, KH; Cha, BY; Jung, CK; Kang, MI; Kim, MH; Kim, SH; Ko, SH; Lee, JM; Lee, SH; Lim, DJ | 1 |
| Aoki, H; Fukumoto, T; Kitajima, K; Kono, A; Matsumoto, I; Okunaga, T; Suenaga, Y; Sugimura, K; Tanaka, K | 1 |
| Cho, SH; Kim, SH; Kim, SW; Kim, WC; Oh, ST; Park, JM; Yoo, IeR | 1 |
| Cheze Le Rest, C; Hatt, M; Pradier, O; Tixier, F; Visvikis, D | 1 |
| Julian, J; Levine, MN | 1 |
| Cao, KJ; Cao, Y; Chen, MY; Chen, QY; Fan, W; Guo, L; Guo, X; Hua, YJ; Huang, PY; Li, J; Lin, XP; Liu, H; Liu, LZ; Luo, DH; Lv, X; Mai, HQ; Mo, HY; Mo, YX; Qian, CN; Qiu, F; Sun, R; Tang, LQ; Wang, L; Xiang, YQ; Zeng, MS; Zhang, L; Zhang, X; Zhao, C; Zou, RH | 1 |
| Ikeda, S; Ito, T; Kanazawa, H; Katada, N; Morita, K; Narita, M; Nishimura, D; Okubo, K; Shibahara, H; Takeuchi, A | 1 |
| Bender, LW; Manzil, FF; Scott, JW | 1 |
| Chen, JQ; Huang, Y; Liu, JL; Qin, XG; Wang, Z | 1 |
| Ahn, BC; Hong, CM; Jeong, SY; Lee, J; Lee, SW | 1 |
| Khoo, JB; Tan, NC; Teo, PT | 1 |
| Abe, K; Akamatsu, G; Baba, S; Honda, H; Isoda, T; Kitamura, Y; Maruoka, Y; Mizoguchi, N; Sasaki, M | 1 |
| Boér, K; Borbély, K; Kásler, M; Németh, Z | 1 |
| Bassini, A; Bertola, M; Del Conte, A; Foltran, L; Gion, M; Lorenzon, M; Micheli, E; Saracchini, S; Sulfaro, S; Tuccia, F; Tumolo, S | 1 |
| Berg, WA; Kalinyak, JE; Madsen, KS; Narayanan, D; Schilling, K; Tartar, M | 1 |
| Cho, KJ; Joo, YH; Kim, CS; Kim, MS; Nam, IC; Park, JO; Yoo, IeR | 1 |
| Berriolo-Riedinger, A; Brunotte, F; Cochet, A; Coudert, B; Coutant, C; Dygai-Cochet, I; Fumoleau, P; Guiu, S; Humbert, O; Riedinger, JM; Toubeau, M | 1 |
| An, YS; Jung, YS; Kang, DK; Kim, KS; Kim, TH; Lee, DH; Lee, SJ; Yim, H; Yoon, JK | 1 |
| Kim, DY; Kim, JH; Kim, YM; Kim, YT; Lee, JJ; Lee, SW; Nam, JH; Park, JY; Seo, MJ; Shim, SH | 1 |
| Berriolo-Riedinger, A; Brunotte, F; Charon-Barra, C; Cochet, A; Coutant, C; Desmoulins, I; Dygai-Cochet, I; Fumoleau, P; Gauthier, M; Guiu, S; Humbert, O; Toubeau, M | 1 |
| Berthelsen, AK; Binderup, T; Brinch, K; Brünner, N; Engelmann, BE; Gerds, TA; Højgaard, L; Høyer-Hansen, G; Kjær, A; Kristensen, MH; Kurt, EY; Latocha, JE; Lindblom, G; Loft, A; Nielsen, HJ; Sloth, C | 1 |
| Dong, A; Wang, Y; Zhai, Z; Zhang, J; Zuo, C | 1 |
| Amant, F; De Keyzer, F; Deroose, C; Dymarkowski, S; Leunen, K; Michielsen, K; Moerman, P; Op de Beeck, K; Souverijns, G; Vandecaveye, V; Vergote, I | 1 |
| Bal, C; Dhull, VS; Kumar, R; Maharjan, S; Patel, C; Sharma, DN; Sharma, P; Suman Kc, S | 1 |
| Augereau, P; Menei, P; Morel, O; Patsouris, A; Paumier, A; Rousseau, A; Tanguy, JY | 1 |
| Bal, C; Jain, S; Julka, PK; Karunanithi, S; Kumar, R; Malhotra, A; Pal, S; Sharma, P; Thulkar, S | 1 |
| Guo, Q; Lu, Y; Peng, W; Sun, H; Wang, B; Xin, J; Zhai, W; Zhang, S; Zhao, L | 1 |
| Coleman, RL; Gershenson, DM; Lucchini, M; Macapinlac, HA; Munsell, MF; Ramirez, PT; Schmeler, KM; Takeuchi, S | 1 |
| Abeyakoon, O; Baltzer, P; Bickel, H; Brader, P; Füger, B; Helbich, T; Magometschnigg, HF; Pinker, K; Polanec, S; Wengert, G | 1 |
| Barizzi, J; Bongiovanni, M; Ceriani, L; Giovanella, L; Paone, G; Treglia, G | 1 |
| Bal, C; Ballal, S; Jain, TK; Karunanithi, S; Sharma, P; Vijay, MK | 1 |
| Huber, G; Hüllner, M; Kollias, S; Kuhn, F; Meerwein, C; Queiroz, MA; Veit-Haibach, P; von Schulthess, G | 1 |
| Hu, C; Hu, S; Li, D; Pan, H; Shi, W; Yang, Z; Yao, Z; Zhang, Y; Zhu, B | 1 |
| Jeong, YJ; Kang, DY; Son, HJ; Yoon, HJ | 1 |
| Agrawal, K; Bomanji, J; Groves, A; Saad, ZZ; Sajjan, RS; Syed, R | 1 |
| Alkadhi, H; Fischer, MA; Hahnloser, D; Hany, TF; Veit-Haibach, P; Vrugt, B | 1 |
| Blake, P; Chan, D; Fielding, P; Foley, KG; Karran, A; Lewis, WG; Roberts, SA | 1 |
| Han, J; Hu, S; Ke, S; Lei, G; Li, C; Liu, Z; Lu, M; Ran, H; Wang, W; Yang, G; Zhang, F; Zhang, T; Zhang, W; Zhang, Y; Zou, C | 1 |
| Öztürk, H | 1 |
| Jeon, YK; Kim, BH; Kim, IJ; Kim, SJ; Kim, SS; Kim, YK; Lee, SH | 1 |
| Cho, A; Kang, WJ; Kim, YT; Lee, JD; Lee, JH; Lee, JW; Yun, M | 1 |
| Brindle, R; Gandhi, A; Mullan, D; Yap, BK | 1 |
| Brendle, C; Claussen, CD; Gatidis, S; Königsrainer, I; Müller, M; Pfannenberg, AC; Schmidt, H; Schraml, C; Schwenzer, NF | 1 |
| Li, ZG; Qin, XJ | 1 |
| Ding, L; Dong, L; Liu, B; Liu, M; Song, Y | 1 |
| Borges, US; da Silva, BB; Gebrim, LH; Lopes-Costa, PV; Pires, AO | 1 |
| Kang, H; Marcus, C; Mohandas, A; Subramaniam, RM; Truong, MT | 1 |
| Capirci, C; Chondrogiannis, S; Crepaldi, G; Fornasiero, A; Galeotti, F; Grassetto, G; Maffione, AM; Marzola, MC; Rampin, L; Rubello, D | 1 |
| Hu, C; Shi, Q; Yang, Z; Zhang, Y | 1 |
| Kim, SH; Song, BI; Won, KS | 1 |
| Agrawal, A; Purandare, NC; Puranik, AD; Rangarajan, V; Shah, S | 1 |
| Fukui, M; Inoue, D; Ishitoko, M; Itotani, R; Matsumoto, M; Nakayama, T; Sakuramoto, M; Suzuki, S; Takamatsu, K; Takemura, M; Yoshie, O; Yuba, Y | 1 |
| Barker, DW; Finegold, MJ; Hall, NC; Hingsbergen, EA; Samarghandi, A | 1 |
| Dave, SR; Pucar, D; Samuel, TA; Savage, N; Williams, HT | 1 |
| Aleman, BM; Boot, H; Sanders, J; Stiekema, J; van Sandick, JW; Vegt, E; Vermeulen, D; Voncken, FE | 1 |
| Deng, J; Shen, N; Tang, J | 1 |
| Aktas, B; Beiderwellen, K; Buderath, P; Forsting, M; Grueneisen, J; Heusch, P; Kraff, O; Lauenstein, TC; Ruhlmann, V; Umutlu, L | 1 |
| Cho, KS; Hong, SL; Kim, SJ; Lee, SH; Roh, HJ; Yoon, YH | 1 |
| Ginsberg, MS; Hayes, SA; Plodkowski, AJ | 1 |
| Doudouh, A; El Hammoumi, M; El Marjany, M; Kabiri, el H; Mansouri, H; Moussaoui, D | 1 |
| Chondrogiannis, S; Colletti, PM; Fuster, D; Giammarile, F; Grassetto, G; Maffione, AM; Marzola, MC; Musto, A; Rampin, L; Rubello, D | 1 |
| Deng, H; Jia, Z; Li, J; Shen, G; Wang, Q; Zhang, W | 1 |
| de Roquancourt, A; Delord, M; Espié, M; Giacchetti, S; Groheux, D; Hamy, AS; Hindié, E; Merlet, P | 1 |
| Antonelli, A; Grosso, M; Guidoccio, F | 1 |
| Hattori, N; Hirata, K; Kato, F; Magota, K; Manabe, O; Mimura, R; Sakuragi, N; Sudo, S; Sugimori, H; Tamaki, N | 1 |
| Choi, JY; Jung, HK; Jung, SA; Kim, SE; Shim, KN; Yoo, K | 1 |
| Cai, L; Chen, Y; Huang, Z; Wu, J; Zhang, Y | 1 |
| Ahn, SG; Dong, SM; Han, K; Jeon, TJ; Jeong, J; Lee, HM; Lee, HW; Lee, SA; Park, JT; Ryu, YH; Son, EJ | 1 |
| Kim, J; Seltzer, M; Siegel, A; Yen, SP | 1 |
| Li, XD; Liu, WK; Ouyang, X; Quan, JT; Zheng, H | 1 |
| Al Ghuzlan, A; Baudin, E; Berdelou, A; Borget, I; Deandreis, D; Hartl, D; Leboulleux, S; Lepoutre-Lussey, C; Lumbroso, J; Mirghani, H; Nascimento, C; Schlumberger, M | 1 |
| Bhasin, D; Bhattacharya, A; Gupta, R; Kang, M; Kapoor, R; Mittal, BR; Rana, S; Santhosh, S | 1 |
| Goh, BC; Khor, LK; Loh, KS; Loi, HY; Lu, SJ; Sinha, AK; Tong, KT | 2 |
| Fu, DL; Guan, YH; Jin, C; Wang, XY; Yang, F; Zhang, HW | 1 |
| Duong, C; Hicks, RJ; Kaneko, Y; Link, E; Murray, WK | 1 |
| Achtari, C; Meuli, RA; Prior, JO; Schmidt, S | 1 |
| Ebina, Y; Kanda, T; Kitajima, K; Kubo, K; Maeda, T; Okunaga, T; Sofue, K; Suenaga, Y; Sugimura, K; Tamaki, Y; Ueno, Y; Yamada, H | 1 |
| Chen, QY; Guo, SS; Guo, X; Li, PJ; Liu, LT; Luo, DH; Mai, DM; Mai, HQ; Mo, HY; Qian, CN; Shen, T; Tang, LQ; Zeng, MS | 1 |
| Chen, TT; Chiu, CF; Hsieh, CY; Hsieh, TC; Hua, CH; Lin, CC; Lin, CY; Sher, YP; Yang, TY; Yeh, SP | 1 |
| Jiang, C; Lei, J; Li, J; Yan, R | 1 |
| Iyamu, I; Mathews, D; Peng, F; Truelson, J; Wachsmann, J | 1 |
| Kawase, T; Kubota, K; Naka, G; Sakashita, B; Takeda, Y | 1 |
| Bryant, R; Burge, ME; Cavallucci, D; Eastgate, M; Finch, R; Francesconi, A; Hopkins, G; Houston, K; Macfarlane, D; O'Rourke, N; Thomas, P; Wyld, D | 1 |
| Biondi, B; Rufini, V; Salvatori, M | 1 |
| Chang, S; Kim, SJ | 1 |
| Cho, A; Kim, EK; Kwak, JY; Lee, HS; Moon, HJ; Yoon, JH | 1 |
| Deng, H; Jia, Z; Shen, G; Wang, Q; Zhang, W; Zhou, L | 1 |
| Chen, L; Hu, W; Wang, Y; Wei, G; Xian, W; Zhang, N | 1 |
| Chiu, YL; Lee, SD; Peng, NJ; Wu, CS | 1 |
| Biermann, M; Bjørge, L; Haldorsen, IS; Husby, JA; Magnussen, IJ; Reitan, BC; Salvesen, HB; Salvesen, ØO; Trovik, J | 1 |
| Huang, B; Khong, PL; Kwong, DL; Lai, V; Wong, CY | 1 |
| Kroiss, A; Uprimny, C; Virgolini, IJ | 1 |
| Baumann, M; Bütof, R; Hofheinz, F; Jentsch, C; Kotzerke, J; Löck, S; Schmollack, J; Stadelmann, T; van den Hoff, J; Zöphel, K | 1 |
| Chen, W; Feng, Q; Huang, M; Jiang, J; Wang, Q; Wu, H; Wu, Y; Yang, W; Zhao, J | 1 |
| Bom, HS; Chong, A; Jung, SH; Kim, J; Kwon, SY; Min, JJ; Song, HC | 1 |
| Brekke, N; Fonnes, T; Haldorsen, IS; Kopperud, R; Krakstad, C; McCormack, E; Pavlin, T; Popa, M; Rygh, CB; Salvesen, HB; Visser, NC | 1 |
| Carvalho, DP; Vaisman, F; Vaisman, M | 1 |
| Al Tamimi, AS; Ng, DC; Osmany, S; Zaheer, S | 1 |
| Chegai, F; Mannelli, L; Monti, S; Orlacchio, A | 1 |
| Balsa-Bretón, MÁ; Guijarro-Armas, G; Merino-Viveros, M; Pavón-Paz, I; Penín-Gonzalez, FJ; Rosado-Sierra, JA | 1 |
| Cestari, DM; Leskov, I; Rasool, N | 1 |
| Bach, AM; Fish, SA; Tuttle, RM; Yang, SP | 1 |
| Hsieh, TC; Kao, CH; Lin, CC; Sun, SS; Wu, YC | 1 |
| Jun, S; Kim, H; Nam, HY | 1 |
| Ji, YH; Lv, L; Tian, Y; Wang, QS; Wang, SB; Wu, HB; Zhou, WL | 1 |
| Cao, KJ; Chen, QY; Chen, WH; Fan, W; Guo, L; Guo, SS; Guo, X; Liu, LT; Mai, HQ; Qian, CN; Tang, LQ; Xie, D; Zeng, MS; Zhang, L; Zhang, X; Zhao, C | 1 |
| Bae, SK; Ha, TK; Jung, SJ; Kim, TH; Lee, SM; Park, JS; Urm, SH; Yoon, M | 1 |
| Cai, H; Li, L; Shen, G; Zhang, W; Zhou, H; Zhou, Y | 1 |
| Pei, S; Wei, J; Zhu, X | 1 |
| Chen, CL; Chen, NF; Chih-Chuan, H; Li, CC; Li, CZ; Lin, MC; Tang, CT | 1 |
| An, YS; Chung, YS; Kim, JH; Lee, SJ; So, EY; Yoon, JK; Yoon, S | 1 |
| Ahn, BC; Jeong, SY; Jung, JH; Kim, CY; Kim, DH; Lee, J; Lee, SW; Son, SH | 1 |
| Cho, BC; Keum, KC; Kim, KH; Lee, CG; Lee, J; Roh, YH; Yoon, HI; Yun, M | 1 |
| Chan, HY; Ho, JC; Lee, EY; Tsoi, A; Wong, MP | 1 |
| Abu-Rustum, NR; Benz, M; Hricak, H; Lyons, G; Robertson, NL; Sala, E; Sonoda, Y; Sosa, RE; Vargas, HA | 1 |
| Dhull, VS; Khangembam, BC; Kumar, R; Kumar, S; Rana, N; Shamim, SA; Sharma, D; Sharma, P; Verma, S | 1 |
| Li, ZG; Lin, ZC; Mu, HY | 1 |
| Chen, YZ; Li, WF; Ou, RY; Wang, JM; Wang, JY; Xu, YS; Zhao, L; Zheng, XW | 1 |
| Chen, L; Li, WF; Liu, Q; Ma, J; Mao, YP; Peng, H; Sun, Y; Zhang, Y; Zhou, GQ | 1 |
| Bal, C; Damle, NA; Taywade, SK | 1 |
| Chiba, T; Haga, H; Hatano, E; Isoda, H; Kodama, Y; Kurita, A; Kuriyama, K; Minamiguchi, S; Nakamoto, Y; Sawai, Y; Togashi, K; Uemoto, S; Uza, N; Yoshimura, K | 1 |
| Denis, F; Krhili, S; Muratet, JP; Pointreau, Y; Roche, S; Septans, AL; Yossi, S | 1 |
| Han, JK; Hur, BY; Joo, I; Kim, SH; Lee, DH | 1 |
| Fox, J; Krebs, S; Mannelli, L; Monti, S; Seshan, S | 1 |
| Buchpiguel, CA; Coutinho, AM; de Menezes, MR; do Vale, RH; Queiroz, MA | 1 |
| Bray, V; Chicco, A; Forstner, D; Fowler, A; Holloway, L; Lee, M; Lin, P; Min, M; Xuan, W | 1 |
| Al-Thaqfi, S; Hadb, A; Naddaf, SY; Syed, GM | 1 |
| Behrendt, FF; Eble, MJ; Heinzel, A; Mohammadkhani Shali, S; Mottaghy, FM; Schmitt, V; Verburg, FA; Winz, OH | 1 |
| Chan, SC; Chang, KP; Fang, YD; Hsu, CL; Liao, CT; Ng, SH; Tsang, NM; Yen, TC | 1 |
| Chen, CY; Hsiao, YC; Hsieh, BT; Huang, WS; Ooi, H | 1 |
| Campbell, R; Campbell, RG; Carrau, RL; Ditzel, L; Elkhatib, AH; Filho, LF; Hachem, RA; Prevedello, DM; Prevedello, L; Soldatova, L | 1 |
| Gobara, H; Iguchi, T; Inai, R; Kanazawa, S; Sato, S; Tada, A; Tanaka, T; Yanai, H | 1 |
| Yoon, SN | 1 |
| Javadi, MS; Rowe, SP; Solnes, LB | 1 |
| Allemann, P; Jreige, M; Pomoni, A; Prior, JO; Van Der Gucht, A | 1 |
| Ahn, MJ; Ahn, YC; Cho, YS; Choi, JY; Kim, BT; Lee, KH; Moon, SH; Son, YI | 1 |
| Andrade, RJ; Cascales-Campos, PA; Feliciangeli, E; Frutos, L; Fuster-Quiñonero, M; Gil, E; Gil, J; Lopez-Lopez, V; Parrilla, P | 1 |
| Dai, D; Dong, YW; Fu, Q; Li, XF; Liu, JJ; Song, XY; Xu, WG; Zuo, C | 1 |
| Chowdhury, F; Cooper, R; Patel, C; Scarsbrook, A; Swift, S; Vaidyanathan, S | 1 |
| Cho, KS; Kim, BS; Kim, IJ; Pak, K; Roh, HJ; Yi, KI | 1 |
| Cheng, X; Cui, R; Zhu, W | 1 |
| Lu, CH; Lu, YY; Wang, HY | 1 |
| Bellendorf, A; Bockisch, A; Forsting, M; Grafe, H; Grueneisen, J; Ruhlmann, M; Ruhlmann, V; Sawicki, LM; Umutlu, L | 1 |
| Baudin, E; Berdelou, A; Bidault, F; Borget, I; Deandreis, D; Dercle, L; Deschamps, F; Hartl, D; Leboulleux, S; Lumbroso, J; Ricard, M; Schlumberger, M; Terroir, M; Tselikas, L | 1 |
| Colletti, PM; Dubreuil, J; Giammarile, F; Glehen, O; Rousset, P; Rubello, D; Skanjeti, A | 1 |
| Baroli, A; Crivelli, F; Gilardi, L; Lomuscio, G; Vadrucci, M | 1 |
| Li, H; Liao, G; Lin, J; Wang, B; Xie, G; Yan, M; Yuan, Y | 1 |
| Enoki, E; Hosokawa, C; Kashiwagi, N; Murakami, T; Sakaguchi, K | 1 |
| Kim, JS; Kim, SY; Lee, JH; Nam, SY; Oh, JS; Park, MJ; Roh, JL | 1 |
| Hu, J; Ji, YH; Lv, L; Shou, T; Wang, QS; Wang, SB; Wu, HB; Zhou, WL | 1 |
| Azar, N; Cui, M; Li, Y; Michael, CW; Nakamoto, D | 1 |
| Bom, HS; Cho, IH; Choi, EK; Chong, A; Chun, KA; Ha, JM; Kim, J; Kim, SH; Kong, EJ; Kwon, SY; Min, JJ; O, JH; Song, HC | 1 |
| Grigsby, PW; Lin, LL; Miller, TR; Schwarz, JK; Siegel, BA | 1 |
| Balan, A; Mirsadraee, S; Naik, K; Salahudeen, HM; Scarsbrook, AF | 1 |
| Allen, TW; Davison, JM; Holley, TS; Jurgens, JS; Montilla-Soler, JL; Stack, AL; Stocker, DJ | 1 |
| Hoshikawa, H; Mitani, T; Mori, N; Nishiyama, Y; Ohkawa, M; Yamamoto, Y | 1 |
| Bogsrud, TV; Hay, ID; Karantanis, D; Kasperbauer, JL; Lowe, VJ; Mullan, BP; Nathan, MA; Reading, CC; Wiseman, GA | 1 |
| Finestone, H; Geller, MD; Gerard, PS; Lazzaro, R | 1 |
| Akashi, T; Chiba, T; Ito, H; Ito, K; Kubota, K; Mochizuki, M; Morita, T; Morooka, M; Murata, Y; Nomura, T; Shibuya, H | 1 |
| Beldì, D; Brambilla, M; Deantonio, L; Gambaro, G; Inglese, E; Krengli, M; Loi, G | 1 |
| Hattori, H; Matsuoka, H; Nishimura, H; Yamamoto, K | 1 |
| Chen, Y; Huang, G; Liu, J; Sun, X; Tong, J; Xue, H; Zhang, C; Zheng, P | 1 |
| Chang, MC; Lin, WY; Tsai, SC | 1 |
| Aschoff, P; Beckert, S; Brücher, BL; Glatzle, J; Hartmann, JT; Königsrainer, A; Königsrainer, I; Miller, S; Pfannenberg, C; Schroeder, TH; Zieker, D | 1 |
| Boussion, N; Cheze-Le Rest, C; Doucet, L; Dupont, E; Kerlan, V; Malecot, JM; Roudaut, N; Visvikis, D | 1 |
| Chua, ET; Chua, ML; Fong, KW; Gao, F; Khoo, JB; Low, JS; Ng, DC; Ong, SC; Tan, TW; Wee, JT | 1 |
| Gambhir, SS; Iagaru, AH; McDougall, IR; Mittra, ES; Quon, A | 1 |
| Doi, R; Hatano, E; Higashi, T; Kami, K; Machimoto, T; Masui, T; Ogawa, K; Seo, S; Uemoto, S | 1 |
| Bradley, KM; Chowdhury, FU; Gleeson, FV | 1 |
| Atmani, A; Bail, JP; Cheze Le Rest, C; Jestin-Le Tallec, V; Lozac'h, P; Metges, JP; Pradier, O; Teyton, P; Visvikis, D; Volant, A | 1 |
| Hwang, JH; Kim, SE; Lee, JK | 1 |
| Chiba, H; Fujii, M; Inomata, S; Nakamura, N; Sawazumi, T; Takahashi, H; Takahashi, M; Tanaka, H | 1 |
| Alberini, JL; Banal, A; Floiras, JL; Gardner, M; Halimi, P; Hans, S; Housset, M; Labib, A; Plantet, MM; Valinta, D; Wartski, M | 1 |
| McCook, BM; Muthukrishnan, A; Narla, VV | 1 |
| D'Ambrosio, D; Degrassi, A; Fanti, S; Farace, P; Galiè, M; Marzola, P; Merigo, F; Nanni, C; Rubello, D; Sbarbati, A; Spinelli, A | 1 |
| Kaji, Y; Kitajima, K; Murakami, K; Sugimura, K; Yamasaki, E | 1 |
| Amemiya, R; Asato, Y; Hashimoto, I; Iijima, H; Kaburagi, T; Kaito, K; Kiyoshima, M; Okumura, T; Sato, M; Uchiumi, K | 1 |
| Aozasa, K; Hatazawa, J; Higuchi, I; Ikeda, N; Inoue, A; Inoue, M; Johkoh, T; Nakamura, H; Okumura, M; Shiono, H; Tatsumi, M; Tomiyama, N | 1 |
| Al-Nahhas, A; Ambrosini, V; Castellucci, P; Cracco, E; Fanti, S; Grassetto, G; Lopci, E; Maffione, AM; Marzola, MC; Massaro, A; Musto, A; Nanni, C; Piva, M; Rampin, L; Rubello, D; Tsamita, CS | 1 |
| Chiti, A | 1 |
| Hartnett, GF; Hughes, BG; Lee, JC; Ravi Kumar, AS | 1 |
| Hara, H; Nonaka, A; Shimada, T; Shiotani, H; Stugaard, M; Ueda, O | 1 |
| Fujii, A; Hayashi, A; Hidaka, D; Hiyama, J; Ikeda, K; Koshizuka, H; Misumi, Y; Miyagawa, Y; Nakatsubo, S; Sawamoto, R | 1 |
| Avigdor, A; Davidson, T; Goitein, O; Goshen, E; Zwas, ST | 1 |
| Broccoli, P; D'Urso, S; Danieli, R; Fusco, N; Maurici, M; Orlacchio, A; Schillaci, O; Simonetti, G; Yamgoue, M | 1 |
| Hara, M; Mizuno, A; Nakagawa, M; Nishio, M; Ozawa, Y; Sakurai, K; Shibamoto, Y; Tamaki, T | 1 |
| Asakura, K; Furukawa, H; Ikuma, H; Uesaka, K | 1 |
| Kita, I; Makino, I; Sato, N; Yamaguchi, T; Yasui, T | 1 |
| Bellomi, M; Bonello, L; Funicelli, L; Landoni, F; Travaini, LL; Trifirò, G | 1 |
| Bertagna, X; Bienvenu, M; Dousset, B; Faraggi, M; Groussin, L; Hignette, C; Joannidis, S; Legmann, P; Libé, R; Richard, B; Tenenbaum, F; Tissier, F | 1 |
| Fu, Z; Kong, L; Sun, XD; Xie, P; Yu, JM; Yue, JB; Zhao, HX | 1 |
| Chan, WK; Huang, B; Khong, PL; Kwong, DL; Mak, HK; Yeung, DW | 1 |
| Digumarthy, SR; Kalra, MK; Prakash, P; Sharma, A; Shepard, JA | 1 |
| Hyodo, M; Kasahara, N; Koizumi, M; Morishima, K; Sakuma, Y; Sasanuma, H; Sata, N; Shimizu, A; Yasuda, Y | 1 |
| Bassi, MC; Brambilla, M; Cannillo, B; Deantonio, L; Inglese, E; Krengli, M; Milia, ME; Mones, E; Sacchetti, G; Turri, L | 1 |
| Inubushi, M; Iwaki, H; Matsunaga, H; Matsushita, A; Nagayama, K; Nakamura, H; Nishizawa, S; Ohba, K; Okada, H; Oki, Y; Sasaki, S; Suzuki, S | 1 |
| Ceriani, L; Giovanella, L; Ravani, P; Ricci, R; Suriano, S | 1 |
| Gao, Y; Lou, Y; Ma, C; Wang, X; Xie, J; Zuo, S | 1 |
| Inoue, T; Kiyoto, S; Nishimura, R; Ohsumi, S; Sugawara, Y; Takabatake, D | 1 |
| Abe, W; Narahara, H; Nasu, K; Takai, N; Tomonari, K | 1 |
| Abe, M; Endo, M; Hanaoka, H; Hayashi, I; Kaira, K; Koh, Y; Kondo, H; Murakami, H; Naito, T; Nakagawa, K; Nakajima, T; Nakamura, Y; Ohde, Y; Okumura, T; Oriuchi, N; Serizawa, M; Takahashi, T; Tominaga, H; Tsuya, A; Yamamoto, N | 1 |
| Cho, KJ; Cho, Y; Choi, SH; Kim, JS; Kim, SB; Kim, SY; Lee, JH; Lee, SW; Nam, SY; Roh, JL; Song, SY; Yoon, DH | 1 |
| Bommireddipalli, S; DePuey, EG; Gadiraju, R; Goel, S; Paniz-MondolFi, A | 1 |
| Bauman, JE; Capell, PT; Carr, LL; Eaton, KD; Goulart, BH; Kell, EM; Mankoff, DA; Martins, RG | 1 |
| Baek, JH; Choi, BS; Choi, JW; Jeong, KS; Kim, TY; Kim, WB; Lee, JH; Ryu, JS; Shong, YK | 1 |
| Busiello, L; Fiorelli, A; Laperuta, P; Mansi, L; Rambaldi, PF; Rotondo, A; Santini, M; Vicidomini, G | 1 |
| Bakhshi, S; Karunanithi, S; Radhakrishnan, V; Tanveer, N; Thulkar, S | 1 |
| Fukukura, Y; Higashi, M; Kamiyama, T; Kurono, Y; Nakajo, M; Ohori, J; Takumi, K | 1 |
| Fox, JJ; Gönen, M; Humm, J; Larson, SM; Meirelles, GS; Morris, MJ; Ravizzini, GC; Scher, HI; Schöder, H | 1 |
| Fujiwara, S; Matsuyama, T; Mori, M; Muroi, K; Nagai, T; Oh, I; Ohmine, K; Ozaki, K; Ozawa, K; Sato, K; Suzuki, T | 1 |
| Carr, HM; Cuthbertson, DJ; Gardner, CJ; Gosney, J; Macfarlane, IA; Wieshmann, H | 1 |
| Asopa, R; Malhotra, G; Rajan, MG | 1 |
| Bruna-Muraille, C; Cuif-Job, A; Guedec-Ghelfi, R; Liehn, JC; Papathanassiou, D; Pochart, JM | 1 |
| Conde-Muíño, R; Ferrón, JA; Gómez-Río, M; Llamas-Elvira, JM; Martín-Cano, J; Palma, P; Rodríguez-Fernández, A; Sánchez-Sánchez, R; Segura-Jiménez, I | 1 |
| Buck, AK; Frechen, D; Kley, H; Krüger, S; Maschke, S; Mottaghy, FM; Pauls, S; Reske, SN; Wibmer, T | 1 |
| Bammens, B; Hermans, G; Kuypers, D; Meersseman, P; Meersseman, W; Sciot, R; Van Aken, B | 1 |
| Christensen, T; Ewertz, M; Fisker, R; Fründ, ET; Grankvist, J; Iyer, V; Larsson, EM; Simonsen, C; Stenbygaard, L | 1 |
| Choi, I; Lee, HJ; Nam, KT; Peterson, TE; Price, RR; Tantawy, MN | 1 |
| Delbeke, D; Martin, WH | 1 |
| Alavi, A; Basu, S; Rosenbaum, J; Urhan, M | 1 |
| Dalus, K; Holzmannhofer, J; Kronberger, C; Pirich, C; Reitsamer, R; Rendl, G; Rettenbacher, L | 1 |
| Buvat, I; Emonts, P; Flamen, P; Garcia, C; Hendlisz, A; Necib, H; Vanderlinden, B; Wagner, A | 1 |
| Bentivegna, E; Duvillard, P; Gouy, S; Haie-Meder, C; Leboulleux, S; Lumbroso, J; Morice, P; Uzan, C | 1 |
| de Geus-Oei, LF; de Wilt, JH; Netea-Maier, RT; Oyen, WJ; van der Wilt, GJ; Vriens, D | 1 |
| Bertolaccini, L; Bianchi, A; Biggi, A; Campione, A; Comino, A; Luzzi, L; Rizzardi, G; Terzi, A | 1 |
| Cameron, K; Golan, S; Kostakoglu, L; Labow, D; Peti, S; Roayaie, S; Simpson, W | 1 |
| Lindskog, DM; Nikkhou, K; Talusan, P | 1 |
| Ho, TY; Lin, KJ; Liou, MJ; Yen, TC | 1 |
| Bradley, KM; Gleeson, FV; Khan, Z; Nazir, SA; Patel, CN | 1 |
| Fu, Z; Hu, M; Ju, GF; Kong, L; Ma, YD; Yang, YQ; Yu, JM; Zhang, GL; Zhang, PL; Zhao, W | 1 |
| Chen, HC; Chen, MK; Hung, GU; Lee, HS; Wu, IS; You, WC | 1 |
| Hattori, S; Hayabuchi, N; Hiromatsu, Y; Ishibashi, M; Kage, M; Kaida, H; Kawahara, A; Kobayashi, M; Kurata, S; Mihashi, H; Nakashima, T; Taira, T; Uchida, M; Umeno, H; Yamada, K | 1 |
| Hong, JH; Kim, SE; Lee, JK; Lee, KW; Lee, NW; Song, SH | 1 |
| Chong, A; Heo, SH; Jeong, SY; Lim, JH; Min, JJ; Oh, JR | 1 |
| Chan, SC; Chang, CJ; Chang, JT; Liao, CT; Lin, CY; Lin, SY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Choi, WH; Chung, YA; Han, EJ; Lee, SH; Sohn, HS | 1 |
| Chen, JH; Jeng, LB; Kao, CH; Liang, JA; Lin, CC; Lin, CY | 1 |
| Chen, ZP; Lu, YC; Mou, YG; Sai, K; Wang, ZN; Wei, DN; Yang, QY; Zhang, XH | 1 |
| Han, JM; Jeon, MJ; Kim, TY; Kim, WB; Rhim, SC; Shong, YK; Yim, JH | 1 |
| Feng, HJ; Hu, R; Liu, JH; Ouyang, W; Sun, YG | 1 |
| Chan, WK; Huang, B; Khong, PL; Kwong, DL; Yeung, DW | 1 |
| Abramson, S; Meyers, P; Price, AP; Rosenbaum, DG; Teruya-Feldstein, J | 1 |
| Hsieh, TC; Hsu, CN; Kao, CH; Sun, SS; Wu, YC; Yang, CF; Yen, KY | 1 |
| Kotek, A; Parlak, C; Pehlivan, B; Topkan, E; Yapar, AF | 1 |
| Cui, L; Gao, J; Guan, Z; Shen, Z; Tian, J; Wang, H; Xu, B; Yao, S | 1 |
| Chan, SC; Chang, KP; Chung, MJ; Hsu, CL; Liao, CT; Lo, CW; Ng, SH; Tsang, NM; Wang, HM; Yen, TC | 1 |
| Bae, JS; Baek, KH; Cha, BY; Kang, MI; Kim, MH; Kim, SH; Ko, SH; Lee, JM; Lee, KW; Lim, DJ; O, JH | 1 |
| Bengua, G; Hasegawa, M; Ishikawa, M; Katoh, N; Onimaru, R; Shiga, T; Shimizu, S; Shirato, H; Tamaki, N; Yasuda, K | 1 |
| de Casso, C; Kane, T; Nigam, A; Soni-Jaiswall, A; Visvanathan, V | 1 |
| Cho, KS; Kang, DW; Kim, HJ; Lee, JK; Roh, HJ | 1 |
| Gao, X; Geng, J; Qin, Y; Tian, M; Wang, D; Yu, L | 1 |
| Chang, MC; Chen, JH; Cheng, KY; Kao, CH; Liang, JA; Yang, KT | 1 |
| Bartel, T; Bodenner, D; Boeckmann, J; Siegel, E; Stack, BC | 1 |
| Marcus, DM; Shim, H; Shu, HK; Zhu, A | 1 |
| Cheng, X; Liang, ZY; Lin, YS; Qiu, LH | 1 |
| Debaere, T; Duclos, J; Gouy, S; Haie-Meder, C; Lumbroso, J; Morice, P; Souadka, A; Uzan, C | 1 |
| Lin, JC; Lin, PJ; Wang, WY | 1 |
| Campbell, DB; Crist, HS; Kaul, S; Manni, A; Tulchinsky, M | 1 |
| Gao, X; Tian, M; Yu, L; Zhang, Y | 1 |
| Cheng, J; Hu, S; Pan, L; Xu, J; Yang, Z; Ye, D; Zhang, Y | 1 |
| Bom, HS; Byun, BH; Chong, A; Hong, SP; Jeong, UG; Min, JJ; Song, HC | 1 |
| Aschoff, P; Bruecher, B; Claussen, CD; Klumpp, BD; Koenigsrainer, A; Kramer, U; Miller, S; Pfannenberg, C; Schwenzer, N | 1 |
| Han, A; Hu, M; Wang, X; Xue, J; Zheng, J | 1 |
| Kim, BS; Kim, IJ; Kim, K; Kim, SJ; Pak, K | 1 |
| Cheuk, DK; Hossain, M; Krasin, MJ; Naik, M; Rodriguez-Galindo, C; Sabin, ND; Shulkin, BL; Wozniak, A | 1 |
| Aridome, K; Jinguji, M; Kajiya, Y; Mori, S; Nakajo, M; Suenaga, T; Tanaka, S | 1 |
| Araz, M; Ibis, E; Kucuk, NO; Ozkan, E; Soydal, C | 1 |
| Borbély, K; Fülöp, M; Kásler, M; Lengyel, Z; Remenár, E | 1 |
| Chen, S; Lin, Q; Sun, L; Wu, H; Yang, R | 1 |
| Busk, M; Bussink, J; Engelholm, SA; Hansen, AE; Jørgensen, JT; Kjær, A; Kristensen, AT; McEvoy, FJ; van der Kogel, AJ | 1 |
| Chan, T; Chan, WK; Huang, B; Khong, PL; Kwong, DL | 1 |
| Henne-Bruns, D; Hillenbrand, A; Luster, M; Ohlhauser, D; Reske, SN; Weber, T | 1 |
| Bellon-Guardia, M; Lozano-Martin, E; Perez-Romasanta, LA; Sanz-Martin, M; Torres-Donaire, J; Velasco-Jimenez, J | 1 |
| Baek, CH; Choe, YS; Choi, JY; Jeong, HS; Kim, BT; Lee, KH; Moon, SH; Oh, YL; Son, YI | 1 |
| Iagaru, A; Jeffrey, RB; McDougall, IR; Mosci, C | 1 |
| Aukema, TS; Gilhuijs, KG; Koolen, BB; Lips, EH; Rodenhuis, S; Rutgers, EJ; Valdés Olmos, RA; van Werkhoven, E; Vogel, WV; Vrancken Peeters, MJ; Wesseling, J | 1 |
| Lee, H; Lee, HJ; Luci, JJ; Nam, KT; Peterson, TE; Price, RR; Tantawy, MN | 1 |
| Li, S; Li, X; Liang, B; Lin, S; Liu, X; Lu, J; Peng, X; Wu, H; Yu, L | 1 |
| Chan, SC; Hsu, CL; Liao, CT; Ng, SH; Wang, HM; Yen, TC | 1 |
| An, GI; An, YS; Cheon, GJ; Choi, TH; Chung, WY; Kim, RM; Lee, J; Nah, KY; Oh, YJ; Soh, EY; Yoon, JK | 1 |
| Gerrard, G; Patel, CN; Prestwich, RJ; Scarsbrook, AF; Viner, S | 1 |
| Clark, OH; Duh, QY; Gosnell, J; Guerrero, MA; Munoz-Perez, N; Rinkes, IH; Schreinemakers, JM; Shen, WT; Suh, I; Vriens, MR | 1 |
| Aktolun, C; Celen, YZ; Elboga, U; Kalender, E; Yilmaz, M | 1 |
| Drage, MG; Haddad, RI; Lichtman, AH; Shah, SM | 1 |
| Li, H; Lv, Y; Tian, Y; Wang, Q; Wu, H; Zheng, H; Zhou, W | 1 |
| Altini, C; Giganti, M; Merenda, N; Niccoli Asabella, A; Notaristefano, A; Rubini, D; Rubini, G; Stabile Ianora, AA | 1 |
| Brændengen, M; Glimelius, B; Hansson, K; Isacsson, U; Norrlid, O; Radu, C | 1 |
| Aydin, T; Mulazimoglu, M; Tamam, MO | 1 |
| Baruch-Hennequin, V; Cattan, P; Chirica, M; Cuenca, X; Gornet, JM; Hennequin, C; Hindié, E; Quéro, L; Rivera, S; Vercellino, L | 1 |
| Kwee, RM; Vliegen, RF | 1 |
| Byun, JY; Cho, SM; Ha, HK; Kim, CJ; Lee, JM; Nam-Koong, SE | 1 |
| Delbeke, D; Vitola, J | 1 |
| Lentz, SS | 1 |
| Brouwer, J; Comans, EF; de Bree, R; Hoekstra, OS; Leemans, CR; Pruim, J; Regelink, G; Roodenburg, JL; Vaalburg, W; van der Laan, BF; Vissink, A | 1 |
| Dunnwald, LK; Gralow, JR; Livingston, RB; Mankoff, DA; Rinn, KJ; Schubert, EK; Stafford, SE | 1 |
| Beckers, C; Foidart, J; Malaise, MG; Thiry, A | 1 |
| Bartenstein, P; Junginger, T; Kneist, W; Menzel, C; Oberholzer, K; Schreckenberger, M | 1 |
| Alavi, A; Chacko, TK; Hickeson, M; Zhuang, H | 1 |
| Barrier, A; Houry, S; Huguier, M; Montravers, F; Talbot, JN; Valinas, R | 1 |
| Laking, GR; Price, PM | 1 |
| Brinkbaeumer, K; Dresel, S; Hahn, K; Hautmann, H; Kellner, W; Moisseev, A; Poellinger, B; Schmid, RA; Weiss, M | 1 |
| Fogarty, GB; Hicks, RJ; Peters, LJ; Rischin, D; Scott, C; Stewart, J | 1 |
| Galen, B; Gourgiotis, L; Guthrie, LC; Patronas, NJ; Reynolds, JC; Sarlis, NJ; Shawker, TH; Skarulis, MC | 1 |
| Bascom, D; Fukui, M; Johnson, JT; McCook, B; Meltzer, C; Snyderman, C; Townsend, DW; Zimmer, LA | 1 |
| Dehdashti, F; Grigsby, PW; Mutch, DG; Siegel, BA | 1 |
| Choi, CW; Choi, SC; Kim, MH; Lee, KH; Ryu, SY | 1 |
| Kawabe, J; Koyama, K; Miyama, M; Ochi, H; Okamura, T; Ozawa, N; Torii, K; Umesaki, N; Yamada, R | 1 |
| Gallowitsch, HJ; Gomez, I; Igerc, I; Kresnik, E; Kumnig, G; Lind, P; Mikosch, P; Stettner, H | 1 |
| Brinkbäumer, K; Dresel, S; Grammerstorff, J; Hahn, K; Pfluger, T; Schmid, R; Schwenzer, K | 1 |
| Chen, T; Hayashi, K; Honda, H; Kaneko, K; Koga, H; Kuwabara, Y; Nakagawa, M; Sakai, S; Sasaki, M; Shioyama, Y; Sugio, K | 1 |
| Akhurst, T; Flores, RM; Gonen, M; Larson, SM; Rusch, VW | 1 |
| Delbeke, D; Hopper, OW; Kikkawa, R; Ludwig, V; Martin, WH | 1 |
| Larson, SM; Macapinlac, HA; Salmon, AS; Turlakow, A; Yeung, HW | 1 |
| Higashi, K; Higuchi, T; Ikeda, R; Kodama, Y; Matsunari, I; Miura, K; Taki, S; Tonami, H; Ueda, Y; Yamamoto, I | 1 |
| Camatte, S; Jeffry, L; Kerrou, K; Lécuru, F; Lelievre, L; Metzger, U; Robin, F; Talbot, JN | 1 |
| Goldsmith, SJ; Kostakoglu, L | 1 |
| Bosi, A; Briganti, V; Castagnoli, A; Dini, C; Pagliai, F; Rigacci, L; Vaggelli, L | 1 |
| Chan, SC; Chang, JT; Chang, YC; Ko, SF; Liao, CT; Ng, SH; Wang, HM; Yen, TC | 1 |
| Borson-Chazot, F; Bournaud, C; Giammarile, F; Hafdi, Z; Houzard, C; Sassolas, G | 1 |
| Eimoto, T; Hara, M; Iida, A; Murase, T; Ogino, H; Shibamoto, Y; Shiraki, N; Tamaki, T | 1 |
| Fukuda, H; Hosono, MN; Inoue, Y; Ishii, K; Kondo, S; Matsumura, A; Okamura, T; Takada, Y; Tashiro, M; Wada, Y; Watanabe, Y; Yamada, R | 1 |
| Akeboshi, M; Hataji, O; Nakatsuka, A; Taguchi, O; Takao, M; Takeda, K; Yamakado, K | 1 |
| Hirahara, F; Inoue, T; Kawano, T; Lee, J; Miyagi, E; Nakagami, Y; Shimada, H; Suzuki, A; Takahashi, N; Togo, S | 1 |
| Helmberger, T; Linke, R; Schroeder, M; Voltz, R | 1 |
| Dehdashti, F; Drebin, JA; Fernandez, FG; Linehan, DC; Siegel, BA; Strasberg, SM | 1 |
| Chan, SC; Chang, YC; Fu, YK; Joseph, CT; Ko, SF; Liao, CT; Lin, WJ; Ng, SH; Wang, HM; Yen, TC | 1 |
| Hustinx, R | 1 |
| Hara, M; Iida, A; Itoh, M; Nishio, M; Shibamoto, Y; Shiraki, N; Tamaki, T | 1 |
| Babin, E; Bénateau, H; Béquignon, A; Chesnay, E; Comoz, F; Desmonts, C; Goullet de Rugy, M; Hamon, M | 1 |
| de Castro, S; Drenth, JP; Jansen, JB; Oyen, WJ; van Goor, H; van Kouwen, MC | 1 |
| Endo, K; Faried, A; Fukai, Y; Fukuchi, M; Kato, H; Kimura, H; Kuwano, H; Manda, R; Masuda, N; Miyazaki, T; Nakajima, M; Ojima, H; Oriuchi, N; Sohda, M; Takita, J; Tsukada, K | 1 |
| De Wever, W; Ectors, N; Flamen, P; Haustermans, K; Hiele, M; Lerut, T; Van Cutsem, E; Vrieze, O | 1 |
| Kula, Z; Pietrzak, T; Romanowicz, G; Szefer, J; Zuchora, Z | 1 |
| Cerfolio, RJ; Chen, VK; Desmond, R; Eloubeidi, MA; Ojha, B; Syed, S | 1 |
| Chan, SC; Chang, JT; Chang, YC; Fu, YK; Hsu, CH; Lin, KJ; Lin, WJ; Ng, SH; Yen, TC | 1 |
| Bueno, JG; Domínguez Grande, ML; Fernández, JP; Kosvintseva, O; Oromendía, AO; Pozo, MA; Suárez, AM; Zomeño, M | 1 |
| Bossuyt, A; Everaert, H; Lahoutte, T; Poppe, K; Velkeniers, B | 1 |
| Koshy, M; Paulino, AC; Rusthoven, KE | 1 |
| Chen, TH; Hong, RL; Pan, MH; Tzen, KY; Yen, RF | 1 |
| Chan, SC; Chang, JT; Chang, YC; Chen, IH; Chen, TM; Kang, CJ; Liao, CT; Lin, CY; Lin, KJ; Ng, SH; Wang, HM; Yen, TC | 1 |
| Low, SC; Sinha, AK; Sundram, FX | 1 |
| Endo, K; Higuchi, T; Kanuma, T; Khan, N; Oriuchi, N; Yoshizaki, A | 1 |
| Dehdashti, F; Gibb, RK; Grigsby, PW; Lamoreaux, WT; Mutch, DG; Powell, MA; Rader, JS; Siegel, BA; Zoberi, I | 1 |
| Maeda, M; Ozawa, T; Takekuma, M; Torizuka, T; Yasumi, K | 1 |
| Avril, N; Bader, M; Dose Schwarz, J; Hemminger, G; Jänicke, F; Jenicke, L | 1 |
| Deniaud-Alexandre, E; El Balaa, H; Foulquier, JN; Gendre, JP; Grahek, D; Grange, JD; Grès, B; Hourry, S; Keraudy, K; Kerrou, K; Lerouge, D; Montravers, F; Moureau-Zabotto, L; Petenief, Y; Talbot, JN; Tiret, E; Touboul, E | 1 |
| Hung, GU; Lin, WY; Tsai, SC | 1 |
| Chahlavi, A; Staugaitis, SM; Vogelbaum, MA; Yahya, R | 1 |
| Dresel, S; Hahn, K; Herzog, P; Hungerhuber, E; Reiser, M; Scher, B; Schneede, P; Seitz, M; Tiling, R | 1 |
| Agrawal, A; Nair, N; Nayak, UN | 1 |
| Heiba, SI; Katzel, JA | 1 |
| Bong, JK; Cheong, JH; Cho, A; Hyung, WJ; Lee, JD; Lim, JS; Noh, SH; Yun, M | 1 |
| Alavi, A; Hustinx, R; Zhuang, H | 1 |
| Endo, K; Higuchi, T; Khan, N; Oriuchi, N | 1 |
| Ciernik, IF; Eyrich, GK; Goerres, GW; Schuknecht, B; Stoeckli, SJ; Wild, D | 1 |
| Chan, SC; Chang, JT; Kang, CJ; Liao, CT; Liu, FY; Ng, SH; Ng, SK; Wang, HM; Yen, TC | 1 |
| Boethius, J; Ericson, K; Wang, SX | 1 |
| Barberet, M; Fakhry, N; Giovanni, A; Jacob, T; Mundler, O; Paris, J; Zanaret, M | 1 |
| Hosono, MN; Inoue, Y; Ishii, K; Kondo, S; Maeda, M; Okamura, T; Tada, T; Takada, Y; Wada, Y; Watanabe, Y | 1 |
| Alvarez Pérez, RM; Borrego Dorado, I; Ceballo Pedraja, JM; Esteban Ortega, F; Ruiz Franco-Baux, J; Vázquez Albertino, R | 1 |
| Chen, X; Hadway, J; Lee, TY; Stewart, EE | 1 |
| de Bruin, PC; Koelemij, R; Oreel, MA; Tiel-van Buul, MM; Verzijlbergen, JF | 1 |
| Greer, BE; Rajendran, JG | 1 |
| Bartholeyns, J; Coverdale, J; Eu, P; Hicks, RJ; Lau, E; Mileshkin, L; Prince, HM; Ritchie, D; Thompson, M; Wall, D; Wong, J | 1 |
| Boellaard, R; Crezee, H; Hoekstra, OS; Hulshof, MC; Omloo, JM; Sloof, GW; ten Kate, FJ; van Lanschot, JJ; Vervenne, WL; Westerterp, M | 1 |
| Jacene, HA; Stearns, V; Wahl, RL | 1 |
| Jing-bo, Z; Li-xia, Y; Yan, Z | 1 |
| Inoue, Y; Koyama, K; Matsuoka, T; Nakamura, K; Okamura, T; Okuma, T; Oyama, Y; Wada, Y; Watanabe, Y; Yamamoto, A | 1 |
| de Geus-Oei, LF; Krabbe, PF; Oyen, WJ; Punt, CJ; Ruers, TJ; Wiering, B | 1 |
| Endo, K; Hanaoka, H; Higuchi, T; Iida, Y; Ishikita, T; Koyama, K; Miyakubo, M; Oriuchi, N | 1 |
| Alavi, A; Cohen, AB; Dalmau, J; Galetta, SL; Mathew, RM | 1 |
| Are, C; Hsu, JF; Larson, SM; Schoder, H; Shah, JP; Shaha, AR | 1 |
| Acikgoz, G; Alavi, A; Cermik, TF; Houseni, M; Intenzo, CM; Kim, SM | 1 |
| Kawaguchi, K; Kobayashi, K; Mishima, K; Morita, Y; Saito, I; Seto, K; Uno, K; Yagi, M; Yamada, H | 1 |
| Quint, LE | 1 |
| Gallowitsch, HJ; Gomez, I; Igerc, I; Kohlfuerst, S; Kresnik, E; Lind, P; Matschnig, S | 1 |
| Cho, BY; Choi, MY; Chung, JK; Jeong, JM; Lee, DS; Lee, HY; Lee, MC; Park, DJ; So, Y | 1 |
| Ambrosini, V; Battista, G; Canini, R; Castellucci, P; Fanti, S; Farsad, M; Fiorentini, G; Franchi, R; Moretti, A; Nanni, C; Rampin, L; Rubello, D | 1 |
| Cabrera Martín, MN; Calvo Manuel, F; Carreras Delgado, JL; Pasamontes Pingarrón, JA; Pérez Castejón, MJ; Scola Yurrita, B | 1 |
| Goerres, GW; Paul, SA; Stoeckli, SJ; von Schulthess, GK | 1 |
| Alavi, A; Basu, S | 2 |
| Bhure, U; Gassmann, N; Koma, AY; Steinert, HC; Stöckli, SJ; Strobel, K | 1 |
| Balfe, DM; Ballman, KV; Cerfolio, RJ; Decker, PA; Dehdashti, F; Downey, RJ; Keenan, RJ; Landreneau, RJ; Meyers, BF; Putnam, JB; Reed, CE; Rusch, VW; Siegel, BA | 1 |
| Hamazawa, Y; Inoue, Y; Koyama, K; Okamura, T; Okuma, T; Wada, Y; Wakasa, T; Watanabe, Y | 1 |
| Acikgoz, G; Alavi, A; Cermik, TF; Dadparvar, S; Houseni, M; Mavi, A | 1 |
| Arai, K; Endo, K; Hanaoka, H; Higuchi, T; Iida, Y; Ishikita, T; Koyama, K; Miyakubo, M; Mogi, K; Nakasone, Y; Negishi, A; Oriuchi, N; Paudyal, B; Tsushima, Y | 1 |
| van den Hoff, J | 1 |
| Blocklet, D; Garcia, C; Goldman, S; Moreno-Reyes, R; Stallenberg, B; Tang, BN | 1 |
| Klippenstein, DL; Lamonica, DM | 1 |
| Harada, A; Hayasaka, K; Ito, K; Katoh, T; Kawabata, Y; Matsuura, T; Nakashima, K; Nihashi, T; Sakata, K; Yagi, T | 1 |
| Chang-Yu, W; Chen, MT; Chen, YJ; Li, SH; Wang, SL | 1 |
| Bodenner, DL; King, DL; Spring, PM; Stack, BC; Walker, R | 1 |
| Bjurberg, M; Brun, E; Kjellén, E; Ohlsson, T; Ridderheim, M | 1 |
| Halaç, M; Mut, SS; Ozer, H; Sönmezoglu, K; Uslu, I; Ylmaz, MH | 1 |
| Angoué, O; Biancheri, I; Blagosklonov, O; Boulahdour, H; Kastler, B; Klingelschmitt, S; Legalery, P; Zsigmond, R | 1 |
| Inoue, M; Ito, M; Kawakami, S; Kihara, K; Kobayashi, T; Masuda, H; Numao, N | 1 |
| Bundgaard, T; Buus, S; Grau, C; Hansen, HS; Johansen, J; Keiding, S; Kirkegaard, J; Loft, A; Overgaard, J; Overgaard, M | 1 |
| Han, J; Jeong, SY; Kim, BT; Kim, J; Kim, TS; Lee, KS; Shim, YM | 1 |
| Ambrosini, V; Boschi, F; Fanti, S; Farace, P; Galiè, M; Magnani, P; Marzola, P; Merigo, F; Nanni, C; Nicolato, E; Osculati, F; Sbarbati, A; Spinelli, A; Trespidi, S | 1 |
| Hayashi, T; Ikenaga, N; Nishikawa, K; Otomo, N; Tanaka, M; Toyoda, K; Toyofuku, A; Ueda, Y | 1 |
| Alavi, A; Basu, S; Cermik, T; Chen, W; Czerniecki, B; Mavi, A; Schnall, M; Tchou, J | 1 |
| Al-Nahhas, A; Hindie, E; Rampin, L; Rubello, D; Toubert, ME | 1 |
| Ahuja, AT; Chan, AT; Kam, MK; King, AD; Leung, SF; Ma, BB; Wong, JK; Yau, YY; Zee, B | 1 |
| Fujii, H; Ito, M; Kuwano, H; Saito, N; Tsunoda, Y | 1 |
| Balakrishnan, VB; Chawla, M; Das, CJ; Kumar, R; Malhotra, A | 1 |
| Koyama, H; Maniwa, Y; Nishimura, Y; Nogami, M; Ohbayashi, C; Ohno, Y; Sugimura, K; Takenaka, D | 1 |
| Coleman, RE; Duhaylongsod, FG; Lowe, VJ; Patz, EF; Vaughn, AL; Wolfe, WG | 1 |
| Cappellari, JO; Geisinger, KR; Greven, KM; Keyes, JW; McGuirt, WF; Raben, M; Randall, ME; Watson, NE; Williams, DW | 1 |
| Esselstyn, CB; Kohse, LM; Licata, AA; MacIntyre, WJ; Neumann, DR; Siciliano, D | 1 |
| Dalbohm, NM; Glaspy, JA; Hawkins, RA; Hoh, CK; Moser, EA; Nitzsche, EU; Phelps, ME | 1 |
| Esselstyn, CB; Kim, EY; Neumann, DR | 1 |
| Fazio, F; Fridrich, L; Kendler, D; Landoni, C; Lucignani, G; Messa, C; Moncayo, R; Riccabona, G | 1 |
| Nakai, Y; Ochi, H; Ohashi, Y; Okamura, T; Sakamoto, H | 1 |
| Akashi, Y; Fukumura, T; Ichiya, Y; Kuwabara, Y; Masuda, K; Sasaki, M; Yoshida, T | 1 |
| Ali, A; Alibazoglu, H; Lamonica, G; Megremis, D | 1 |
| Boxt, LM; Fawwaz, R; Plutchok, JJ; Sherman, WH; Van Heertum, RL; Weinberger, J | 1 |
| Bury, T; Hustinx, R; Jacquet, N; Jerusalem, G; Paulus, P; Rigo, P | 1 |
| Rodriguez, M | 1 |
| Dimitrakopoulou-Strauss, A; Gutzler, F; Moehler, M; Raeth, U; Strauss, LG; Stremmel, W | 1 |
| ChangLai, SP; Chieng, PU; Kao, CH; Yen, RF; Yen, TC | 1 |
| James, C; MacGillivray, DC; Starks, M; White, J | 1 |
| Eckel, H; Jungehülsing, M; Pietrzyk, U; Scheidhauer, K; Schicha, H | 1 |
| Bohuslavizki, KH; Clausen, M; Klutmann, S; Kröger, S; Mester, J; Sonnemann, U; Thoms, J; Werner, JA | 1 |
| Aultman, DF; Boykin, KN; Lilien, DL; McDonald, JC; McMillan, RW; Zibari, GB | 1 |
| Aramendia, JM; Brugarolas, A; Crespo, A; Gámez, C; Nicolás, A; Richter, JA; Torre, W | 1 |
| Collins, BT; Dunphy, FR; Lowe, VJ | 1 |
| Altehoefer, C; Hoegerle, S; Nitzsche, EU | 1 |
| Hansen, SB; Keiding, S; Munk, OL; Schiøtt, KM | 1 |
| Dörffler, W; Haller, U; Köchli, OR; Kubik-Huch, RA; Marincek, B; Seifert, B; Steinert, HC; von Schulthess, GK | 1 |
| Chisin, R; Nuñez, RF; Yeung, HW | 1 |
| Kubota, M; Makuuchi, H; Ohta, M; Okumura, A; Saitoh, Y; Shohtsu, A; Suzuki, Y; Tajima, T; Tokuda, Y; Yasuda, S | 1 |
| ChangLai, SP; Chieng, PU; Ho, YJ; Hsieh, JF; Kao, CH; Tsai, SC; Yen, RF | 1 |
| Benard, F; Boileau, R; Mongeau, CJ; Turcotte, E; Verreault, J | 1 |
| Dehdashti, F; Drebin, JA; Linehan, D; Siegel, BA; Strasberg, SM | 1 |
| Birk, D; Buchmann, I; Buck, AC; Diederichs, CG; Guhlmann, CA; Kotzerke, J; Mattfeldt, T; Reske, SN; Schirrmeister, HH; Shen, C | 1 |
| Fischer, U; Georgi, P; Hesse, S; Horn, LC; Kluge, R; Kühnel, G; Seese, A | 1 |
| Becherer, A; Dudczak, R; Kaserer, K; Kletter, K; Leitha, T; Niederle, B; Zettinig, G | 1 |
| Ho, ST; Ho, YJ; Kao, CH; Tsai, SC; Wang, JJ; Yen, RF | 1 |
| Dehdashti, F; Grigsby, PW; Siegel, BA | 1 |
| Franc, B; Gauthier-Koelesnikov, H; Helal, BO; Merlet, P; Prigent, A; Schvartz, C; Syrota, A; Toubert, ME | 1 |
| Delbeke, D; Komori, T | 1 |
| Broelsch, EC; Clausen, M; Frilling, A; Görges, R; Tecklenborg, K; Weber, F | 1 |
| Arslan, N; Rydzewski, B | 1 |
| Kitagawa, Y; Maruta, Y; Nakamura, M; Nishizawa, S; Ogasawara, T; Sadato, N; Sano, K; Yonekura, Y | 1 |
| Endo, K; Inoue, T; Kato, H; Kuwano, H; Miyazaki, T; Nakajima, M; Ojima, H; Oriuchi, N; Tsukada, K; Yoshikawa, M | 1 |
| Dietz, A; Eisenhut, M; Haberkorn, U; Henze, M; Mier, W; Mohammed, A; Nollert, J; Rudat, V | 1 |
| Dresel, S; Hahn, K; Rink, FJ; Rock, C; Schmid, RA; Schwenzer, K; Weiss, M | 1 |
| Ambrus, E; Csernay, L; Farkas, G; Lonovics, J; Papós, M; Pávics, L; Szakáll, S; Takács, T; Trón, L | 1 |
| Haberkorn, U; Schadel, A; Seifert, E; Strauss, LG | 1 |
| Ahonen, A; Joensuu, H; Klemi, PJ | 1 |
47 review(s) available for fluorodeoxyglucose f18 and Carcinoma, Anaplastic
| Article | Year |
|---|---|
18-F fluorodeoxyglucose positron emission tomography/computed tomography findings of bilateral primary fallopian tube carcinoma and metastasis to the uterus: a case report and literature review.
Topics: Carcinoma; Fallopian Tubes; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterus | 2022 |
Liver Injury in Patients With Distal Esophageal Carcinoma After Precision Radiation Therapy: Systematic Review of FDG-PET/CT Patterns.
Topics: Carcinoma; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
Prognostic value of pretreatment 18F-FDG PET-CT for nasopharyngeal carcinoma patients.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Observational Studies as Topic; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2017 |
Peritoneal lymphomatosis: CT and PET/CT findings and how to differentiate between carcinomatosis and sarcomatosis.
Topics: Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2013 |
[An autopsy of G-CSF-producing anaplastic carcinoma of the pancreas with impaired accumulation on FDG-PET after S-1 chemotherapy].
Topics: Aged; Antimetabolites, Antineoplastic; Autopsy; Carcinoma; Drug Combinations; Fatal Outcome; Female; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Oxonic Acid; Pancreatic Neoplasms; Pleurisy; Positron-Emission Tomography; Tegafur | 2013 |
FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: a meta-analysis.
Topics: Carcinoma; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals | 2013 |
Imaging appearances for recurrent nasopharyngeal carcinoma and post-salvage nasopharyngectomy.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nasopharynx; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
[Clinical use of 18F-FDG PET/CT in colorectal carcinoma].
Topics: Carcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Molecular imaging for the characterization of breast tumors.
Topics: Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Estradiol; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mammography; Molecular Imaging; Multimodal Imaging; Positron-Emission Tomography; Proton Magnetic Resonance Spectroscopy; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2014 |
FDG PET/CT in the management of nasopharyngeal carcinoma.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2014 |
Early prediction of response by ¹⁸F-FDG PET/CT during preoperative therapy in locally advanced rectal cancer: a systematic review.
Topics: Carcinoma; Chemoradiotherapy, Adjuvant; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Meta-analysis of diagnosis of liver metastatic cancers: comparison of (18) FDG PET-CT and gadolinium-enhanced MRI.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
Imaging of thoracic cavity tumors.
Topics: Carcinoma; Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Mediastinal Neoplasms; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thymus Neoplasms; Tomography, X-Ray Computed | 2014 |
Role of 18F-FDG PET/CT in the carcinoma of the uterus: a review of literature.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Neoplasms; Uterus | 2014 |
Meta-analysis of diagnostic value of 18F-FDG PET or PET/CT for detecting lymph node and distant metastases in patients with nasopharyngeal carcinoma.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2014 |
Improving patient selection for 18F-FDG PET scanning in the staging of gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Signet Ring Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Observer Variation; Patient Selection; Positron-Emission Tomography; Prospective Studies; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms | 2015 |
Comparison of PET with PET/CT in detecting peritoneal carcinomatosis: a meta-analysis.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Peritoneal Neoplasms; Peritoneum; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Imaging in endocrinology: 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in differentiated thyroid carcinoma: clinical indications and controversies in diagnosis and follow-up.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
[Meta-analysis of PET/CT for diagnosis of residual/recurrent nasopharyngeal carcinoma].
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
A new appraisal of iodine refractory thyroid cancer.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Biological Transport, Active; Carcinoma; Combined Modality Therapy; Disease-Free Survival; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Forecasting; Gene Expression Regulation, Neoplastic; Humans; Iodine Radioisotopes; Molecular Targeted Therapy; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Proteins; Phosphatidylinositol 3-Kinases; Positron-Emission Tomography; Prognosis; Proto-Oncogene Proteins B-raf; Signal Transduction; Survival Rate; Symporters; Thyroid Neoplasms; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases | 2015 |
18F-FDG PET/CT for the Diagnosis of Residual or Recurrent Nasopharyngeal Carcinoma After Radiotherapy: A Metaanalysis.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2016 |
Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2016 |
Polysplenia Syndrome With Splenic and Skeletal Muscle Metastases From Thyroid Carcinoma Evaluated by FDG PET/CT: Case Report and Literature Review: A Care-Compliant Article.
Topics: Aged, 80 and over; Carcinoma; Fluorodeoxyglucose F18; Heterotaxy Syndrome; Humans; Male; Multimodal Imaging; Muscle Neoplasms; Muscle, Skeletal; Positron-Emission Tomography; Splenic Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed | 2016 |
18F-FDG-PET/CT of peritoneal tumors: a pictorial essay.
Topics: Carcinoma; Desmoplastic Small Round Cell Tumor; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Mesothelioma; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Pseudomyxoma Peritonei; Radiopharmaceuticals; Sarcoma; Stomach Neoplasms | 2017 |
Prognostic value of 18F-FDG-PET/CT in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis.
Topics: Carcinoma; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Publication Bias; ROC Curve | 2017 |
Diagnostic value of FDG-PET in recurrent colorectal carcinoma: a meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; ROC Curve; Sensitivity and Specificity | 2009 |
[Selection criteria for peritonectomy with hyperthermic intraoperative chemotherapy (HIPEC) in peritoneal carcinomatosis].
Topics: Antineoplastic Agents; Carcinoma; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Genital Neoplasms, Female; Humans; Hyperthermia, Induced; Laparoscopy; Patient Selection; Peritoneal Neoplasms; Peritoneum; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2008 |
The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma.
Topics: Carcinoma; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed; Whole Body Imaging | 2008 |
Positron-emission tomography in gynaecologic malignancies.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Positron-Emission Tomography; Sarcoma; Sensitivity and Specificity | 2009 |
The role of TSH for 18F-FDG-PET in the diagnosis of recurrence and metastases of differentiated thyroid carcinoma with elevated thyroglobulin and negative scan: a meta-analysis.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Odds Ratio; Radionuclide Imaging; Thyroglobulin; Thyroid Neoplasms; Thyrotropin | 2010 |
The role of [18F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature.
Topics: Biopsy, Fine-Needle; Carcinoma; Confounding Factors, Epidemiologic; Data Interpretation, Statistical; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Thyroid Nodule; Thyroidectomy | 2011 |
Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT).
Topics: Carcinoma; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
18F-FDG PET/CT of cervical carcinoma.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2011 |
18F-FDG PET or PET/CT for detecting extrahepatic metastases or recurrent hepatocellular carcinoma: a systematic review and meta-analysis.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
18F-FDG PET or PET/CT for detection of metastatic lymph nodes in patients with endometrial cancer: a systematic review and meta-analysis.
Topics: Carcinoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Application of metabolic PET imaging in radiation oncology.
Topics: Acetates; Carbon Radioisotopes; Carcinoma; Choline; Confounding Factors, Epidemiologic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Lymphoma; Male; Methionine; Molecular Imaging; Neoplasms; Organ Specificity; Positron-Emission Tomography; Radiation Oncology; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted | 2012 |
Positron emission tomography for evaluation of colorectal carcinoma.
Topics: Carcinoma; Colorectal Neoplasms; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus.
Topics: Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Radiotherapy; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2004 |
PET imaging in assessing gastrointestinal tumors.
Topics: Carcinoma; Colorectal Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
The role of PET-CT fusion in head and neck cancer.
Topics: Carcinoma; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Patient Care Planning; Positron-Emission Tomography; Radiation Injuries; Tomography, X-Ray Computed | 2005 |
Review of fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in the follow-up of medullary and anaplastic thyroid carcinomas.
Topics: Carcinoma; Carcinoma, Medullary; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2005 |
Expanding role of positron emission tomography in cancer of the uterine cervix.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2006 |
[Diagnostic and therapeutic application of 18F-fluoro-deoxy-glucose PET in carcinoma of nasopharynx].
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Neoplasms; Positron-Emission Tomography | 2006 |
PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients.
Topics: Breast Neoplasms; Carcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Tomography, Emission-Computed; Whole Body Imaging | 2006 |
[Impact of FDG-PET in therapeutic management of patients with suspected recurrence of head and neck cancer].
Topics: Aged; Carcinoma; Case Management; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Surveys and Questionnaires | 2006 |
Distant metastases of differentiated thyroid cancer: diagnosis, treatment and outcome.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Practice Patterns, Physicians'; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Whole Body Imaging | 2007 |
The use of imaging studies in the diagnosis and management of thyroid cancer and hyperparathyroidism.
Topics: Carcinoma; Carcinoma, Medullary; Diagnostic Imaging; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hyperparathyroidism; Iodine Radioisotopes; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Parathyroid Hormone; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 1999 |
53 trial(s) available for fluorodeoxyglucose f18 and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Respiratory-gated (4D) contrast-enhanced FDG PET-CT for radiotherapy planning of lower oesophageal carcinoma: feasibility and impact on planning target volume.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Respiratory-Gated Imaging Techniques; Young Adult | 2017 |
Distant metastatic lesions in patients with differentiated thyroid carcinoma. Clinical implications of radioiodine and FDG uptake.
Topics: Carcinoma; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Treatment Outcome | 2013 |
Phase II study of liposome-encapsulated doxorubicin plus cyclophosphamide, followed by sequential trastuzumab plus docetaxel as primary systemic therapy for breast cancer patients with HER2 overexpression or amplification.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Polyethylene Glycols; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Taxoids; Tomography, X-Ray Computed; Trastuzumab | 2013 |
Positron emission tomography/computed tomography for optimized colon cancer staging and follow up.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Receptors, Urokinase Plasminogen Activator; Survival Analysis; Tissue Inhibitor of Metalloproteinase-1; Tomography, X-Ray Computed | 2014 |
Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Diffusion; Diffusion Magnetic Resonance Imaging; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lymph Nodes; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2014 |
Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography-computed tomography for response evaluation in recurrent carcinoma cervix: does metabolic response predict survival?
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; India; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Survival; Uterine Cervical Neoplasms | 2014 |
Predictive value of intratumoral heterogeneity of F-18 FDG uptake for characterization of thyroid nodules according to Bethesda categories of fine needle aspiration biopsy results.
Topics: Adult; Biopsy, Fine-Needle; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule | 2015 |
[Use of 18F-FDG-positron emission tomography in presurgical evaluation of nonspecific or suspectious adrenal masses in non-oncologic patients].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Hyperfunction; Adult; Aged; Area Under Curve; Carcinoma; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2016 |
Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma.
Topics: Adult; Aged; Carcinoma; Diagnostic Imaging; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2009 |
Use of positron emission tomography in surgery follow-up of esophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals | 2009 |
FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2010 |
Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma; Carcinoma, Medullary; Cell Differentiation; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Indoles; Iodine; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Pyrroles; Sunitinib; Thyroid Neoplasms; Tomography, Emission-Computed; Treatment Failure | 2010 |
F-18-2-fluoro-2-deoxyglucose positron emission tomography compared to technetium-99m hexakis-2-methoxyisobutyl isonitrile single photon emission chest tomography in the diagnosis of indeterminate lung lesions.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2010 |
Prognostic value of baseline [18F] fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Carcinoma; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prostatic Neoplasms; Survival Analysis; Technetium Tc 99m Medronate | 2010 |
The value of metabolic imaging to predict tumour response after chemoradiation in locally advanced rectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Rectal Neoplasms; Sensitivity and Specificity | 2010 |
Primary tumor volume measured by FDG PET and CT in nasopharyngeal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Tumor Burden | 2011 |
Prognostic significance of 18F-FDG PET parameters and plasma Epstein-Barr virus DNA load in patients with nasopharyngeal carcinoma.
Topics: Biomarkers, Tumor; Carcinoma; DNA, Viral; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Treatment Outcome; Viral Load | 2012 |
PET/CT for staging and follow-up of pediatric nasopharyngeal carcinoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Biological response of nasopharyngeal carcinoma to radiation therapy: a pilot study using serial 18F-FDG PET/CT scans.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Pilot Projects; Positron-Emission Tomography; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2012 |
Tumor volume delineation in head and neck cancer with 18-fluor-fluorodeoxiglucose positron emission tomography: adaptive thresholding method applied to primary tumors and metastatic lymph nodes.
Topics: Carcinoma; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Multimodal Imaging; Phantoms, Imaging; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Staging of recurrent and advanced lung cancer with 18F-FDG PET in a coincidence technique (hybrid PET).
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer: comparison with F-18 FDG positron emission tomography and extensive conventional radiographic imaging.
Topics: Bone Neoplasms; Carcinoma; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Octreotide; Pentetic Acid; Pleural Neoplasms; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
[18F]FDG imaging of head and neck tumours: comparison of hybrid PET and morphological methods.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Alterations of tumor suppressor genes (Rb, p16, p27 and p53) and an increased FDG uptake in lung cancer.
Topics: Adult; Aged; Carcinoma; Cyclin-Dependent Kinase Inhibitor p16; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Lung Neoplasms; Male; Microfilament Proteins; Middle Aged; Muscle Proteins; Radiopharmaceuticals; Retinoblastoma Protein; Tomography, Emission-Computed; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2003 |
11C-acetate PET imaging of lung cancer: comparison with 18F-FDG PET and 99mTc-MIBI SPET.
Topics: Acetates; Aged; Aged, 80 and over; Carbon; Carcinoma; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed | 2004 |
Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Taiwan | 2004 |
False-positive and true-negative hilar and mediastinal lymph nodes on FDG-PET--radiological-pathological correlation.
Topics: Aged; Carcinoma; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tomography, Emission-Computed | 2004 |
Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response.
Topics: Aged; Carcinoma; Catheter Ablation; Contrast Media; Digestive System Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Fluoroscopy; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Iohexol; Leiomyosarcoma; Lung Neoplasms; Male; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms | 2004 |
Value of 18F-FDG PET in the detection of peritoneal carcinomatosis.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Peritoneal Neoplasms; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis.
Topics: Carcinoma; Chronic Disease; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Combined Modality Therapy; Decision Making; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2005 |
Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?
Topics: Adult; Aged; Carcinoma; Endosonography; Esophageal Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Patient Care Planning; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
[Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
Topics: Adult; Carcinoma; Colon; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Rectum; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.
Topics: Aged; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Endometrial Neoplasms; Esophagoscopy; Female; Fluorodeoxyglucose F18; Granuloma; Histiocytosis; Histoplasmosis; Humans; Kidney Neoplasms; Lung Diseases; Lung Neoplasms; Lymphatic Diseases; Lymphatic Metastasis; Lymphoma; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sarcoidosis; Silicosis; Tomography, X-Ray Computed; Ultrasonography, Interventional; Urinary Bladder Neoplasms | 2005 |
Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Diagnostic accuracy of FDG PET imaging for the detection of recurrent or metastatic gynecologic cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer.
Topics: Adult; Aged; CA-125 Antigen; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Cyclophosphamide; Epirubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Treatment Outcome | 2005 |
[Impact of computed tomography (CT) and 18F-deoxyglucose positron emission tomography (FDG-PET) image fusion for conformal radiotherapy in esophageal carcinoma].
Topics: Adult; Aged; Carcinoma; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Patient Care Planning; Positron-Emission Tomography; Radiometry; Radiopharmaceuticals; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2005 |
18F-FDG PET/CT for staging of penile cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Penile Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
[Evaluation of efficacy and clinical impact of positron emission tomography with 18F fluoro-deoxyglucose (FDG) in patients with suspicion of recurrent laryngeal carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2006 |
In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma.
Topics: Antibodies, Bispecific; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Indium Radioisotopes; Infusions, Intravenous; Infusions, Parenteral; Killer Cells, Lymphokine-Activated; Macrophages; Ovarian Neoplasms; Positron-Emission Tomography | 2007 |
Is there a role for sandostatin treatment in patients with progressive thyroid cancer and iodine-negative but somatostatin-receptor-positive metastases?
Topics: Adenocarcinoma, Follicular; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Octreotide; Organotechnetium Compounds; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Treatment Failure | 2006 |
The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Biopsy, Needle; Carcinoma; Confidence Intervals; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Risk Assessment; Sensitivity and Specificity; Sex Factors; Survival Rate; Thoracotomy | 2007 |
Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for d
Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Hormone-Dependent; Positron-Emission Tomography; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Sensitivity and Specificity; Tomography, Emission-Computed | 2008 |
An evaluation of FDG-PET in the detection and differentiation of thyroid tumours.
Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Child; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Recurrence; Reference Values; Thyroid Hormones; Thyroid Neoplasms; Tomography, Emission-Computed | 1997 |
Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases.
Topics: Adult; Aged; Carcinoma; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 1998 |
Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study.
Topics: Aged; Carcinoma; Colorectal Neoplasms; Databases, Factual; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Missouri; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed | 2001 |
Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiother
Topics: Adolescent; Adult; Aged; Carcinoma; Diagnosis, Differential; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2001 |
Whole-body (18)F-fluorodeoxyglucose positron emission tomography in patients with head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Neoplasms, Second Primary; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Pretreatment evaluation of carcinomas of the hypopharynx and larynx with 18F-fluorodeoxyglucose, 123I-alpha-methyl-L-tyrosine and 99mTc-hexakis-2-methoxyisobutylisonitrile.
Topics: alpha-Methyltyrosine; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Iodine Radioisotopes; Laryngeal Neoplasms; Male; Middle Aged; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2002 |
457 other study(ies) available for fluorodeoxyglucose f18 and Carcinoma, Anaplastic
| Article | Year |
|---|---|
18F-FDG PET/CT in a Patient With Matrix-Producing Carcinoma of the Breast.
Topics: Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |
Pulmonary Sarcomatoid Carcinoma With Epiglottis and Ileum Metastasis Detected by 18F-FDG PET/CT.
Topics: Carcinoma; Carcinoma, Non-Small-Cell Lung; Epiglottis; Fluorodeoxyglucose F18; Humans; Ileum; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Utility of FDG-PET CT scan to detect an incidental rare recurrence of carcinoma urinary bladder following radical cystectomy.
Topics: Carcinoma; Cystectomy; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Urinary Bladder; Urinary Bladder Neoplasms | 2021 |
18F-FDG PET/CT in Bilateral Breasts Metastasis From Ovarian Carcinoma.
Topics: Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
IgA Nephropathy in a Patient With Metastatic Carcinoma of Unknown Primary: Findings on 18F-FDG PET/MRI.
Topics: Adult; Carcinoma; Fluorodeoxyglucose F18; Glomerulonephritis, IGA; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Unknown Primary; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Primary Adrenal Sarcomatoid Carcinoma Detected by 18F-FDG PET/CT.
Topics: Adrenal Gland Neoplasms; Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Port-Site Metastases in Incidentally Detected Carcinoma Gall Bladder: Role of 18F-FDG PET/CT and Patient Outcome.
Topics: Carcinoma; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Liver Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2022 |
Sensitivity of [18F]FDG PET/CT and classification of the primary tumor site in patients with carcinoma of unknown primary.
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2022 |
Solitary Nasopharyngeal Metastasis From Papillary Thyroid Carcinoma Shown on FDG PET/CT.
Topics: Aged; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Neoplasms; Nasopharynx; Positron Emission Tomography Computed Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2022 |
Evaluation of a dog with inflammatory mammary carcinoma using
Topics: Animals; Carcinoma; Dog Diseases; Dogs; Fluorodeoxyglucose F18; Glucose; Multimodal Imaging; Radiopharmaceuticals | 2022 |
Ringed fluorodeoxyglucose uptake predicted poor prognosis after resection of pulmonary pleomorphic carcinoma.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Lung; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2022 |
Topics: Carcinoma; Esophagus; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2022 |
HER2-Negative Schnitzler Metastasis to the Rectum Detected Using 18 F-FDG PET/CT.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectum; Stomach Neoplasms | 2022 |
The differential diagnostic value of dual-phase
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies | 2022 |
Radiation Induced Liver Injury: Collateral Damage Radiologically Simulating Interval Metastasis in Carcinoma Esophagus; a Diagnostic Dilemma Resolved Through Liver Biopsy.
Topics: Aged; Biopsy; Carcinoma; Chemical and Drug Induced Liver Injury, Chronic; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiation Injuries; Retrospective Studies | 2022 |
Solitary Abdominal Wall Metastasis From Rectal Carcinoma Revealed on FDG PET/CT.
Topics: Abdominal Wall; Adult; Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Rectal Neoplasms; Tomography, X-Ray Computed | 2022 |
Melanin-Targeted PET Imaging Sheds Light on Pigment Epithelioma in Corpus Ciliare.
Topics: Adenoma; Carcinoma; Ciliary Body; Female; Fluorodeoxyglucose F18; Humans; Melanins; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Complete Metabolic Response in Adenocarcinoma Lung With Lymphangitic Carcinomatosis.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Carcinoma; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
The prognostic relationship of 18F-FDG PET/CT metabolic and volumetric parameters in metastatic ALK + NSCLC.
Topics: Anaplastic Lymphoma Kinase; Carcinoma; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2022 |
Analysis of image quality by regulating beta function of BSREM reconstruction algorithm and comparison with conventional reconstructions in carcinoma breast studies of PET CT with BGO detector.
Topics: Algorithms; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
A rare case of primary intraosseous carcinoma of the mandible with perineural extension mimicking neurolymphomatosis on [
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Mandible; Neurolymphomatosis; Positron Emission Tomography Computed Tomography | 2023 |
Prognostic value of pretherapeutic FDG PET/CT in non-small cell lung cancer with pulmonary lymphangitic carcinomatosis.
Topics: Carcinoma; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2023 |
68 Ga-FAPI-04 PET/CT In Primary Signet Ring-Like Cell Carcinoma of Prostate With Bone Metastases.
Topics: Aged; Bone Neoplasms; Carcinoma; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Cirrhosis; Male; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostate | 2023 |
Percutaneous cryoablation of follicular thyroid carcinoma metastasis to the pancreas
Topics: Adenocarcinoma, Follicular; Aged; Carcinoma; Cryosurgery; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Pancreas; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms | 2023 |
PET-CT detection of local residual laryngeal carcinoma after definitive (chemo)radiotherapy.
Topics: Carcinoma; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
FDG PET/CT in Primary Retroperitoneal Serous Carcinoma.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retroperitoneal Neoplasms | 2023 |
Exploratory analysis of 64 CuCl 2 PET-CT imaging in carcinoma prostate and its comparison with 68 Ga-PSMA-11 and 18 F-FDG PET-CT.
Topics: Carcinoma; Edetic Acid; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostate; Prostatic Neoplasms | 2023 |
A Case of Primary Esophageal Sarcomatoid Carcinoma Detected by 18F-FDG PET/CT.
Topics: Carcinoma; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2023 |
Superior Identification of Metastatic Lesions by 68 Ga-FAPI-46 to 18 F-FDG PET/CT in a Case of SMARCA4-Deficient Undifferentiated Carcinoma of Stomach.
Topics: Carcinoma; DNA Helicases; Fluorodeoxyglucose F18; Humans; Nuclear Proteins; Positron Emission Tomography Computed Tomography; Stomach; Transcription Factors | 2023 |
Pembrolizumab-Associated Pneumonitis Resembling Lymphangitic Carcinomatosis in a Melanoma Patient.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Melanoma; Middle Aged; Pneumonia; Positron Emission Tomography Computed Tomography | 2023 |
Incidental FAPI Localization in Benign Bone Lesions in a Case of Carcinoma Stomach.
Topics: Bone Diseases; Carcinoma; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Positron Emission Tomography Computed Tomography; Stomach Neoplasms | 2023 |
Diffuse peritoneal carcinomatosis and Sister Mary Joseph nodule in ovarian carcinoma - exquisite demonstration of the peritoneal reflections on [18F]FDG PET/CT.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sister Mary Joseph's Nodule | 2023 |
CT and
Topics: Carcinoma; Fibrosis; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed | 2023 |
Textural features on 18F-FDG PET/CT and dynamic contrast-enhanced MR imaging for predicting treatment response and survival of patients with hypopharyngeal carcinoma.
Topics: Adult; Carcinoma; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Survival Rate | 2019 |
Pulmonary lymphangitic carcinomatosis without concurrent liver metastasis from colon cancer detected using 18F-FDG PET/CT: A case report.
Topics: Aged; Carcinoma; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphangitis; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
The Great Mimicker-Tuberculosis Involving Prostate and Vertebrae Posing as Metastatic Prostate Carcinoma on FDG PET/CT.
Topics: Aged; Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Spine; Tuberculosis | 2020 |
Effect of Arrabidaea chica extract against chemically induced breast cancer in animal model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Bignoniaceae; Breast Neoplasms; Carcinogens; Carcinoma; Catalase; Female; Fluorodeoxyglucose F18; Glutathione Peroxidase; Neoplasms, Experimental; Optical Imaging; Oxidative Stress; Plant Extracts; Positron-Emission Tomography; Radiopharmaceuticals; Rats, Wistar; Reproducibility of Results; Superoxide Dismutase; Time Factors; Treatment Outcome; Vincristine | 2019 |
18F-FDG PET/CT Findings in Metastatic Pilomatrix Carcinoma.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Hair Follicle; Humans; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2020 |
The Role of 18F-FDG PET/CT in staging of gallbladder carcinomas.
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Gallbladder; Gallbladder Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2020 |
Renal granulomas mimicking as malignant renal masses on F18 FDG PET/CT in a case of urothelial carcinoma.
Topics: Carcinoma; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Granuloma; Humans; Kidney Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
18-FDG PET-CT should be included in preoperative staging of gall bladder cancer.
Topics: Aged; Bone Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Liver Neoplasms; Lymph Nodes; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Omentum; Palliative Care; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Survival; Tomography, X-Ray Computed | 2020 |
A rare presentation of primary synchronous renal tract tumours on (18F)- fluorodeoxyglucose positron emission tomography- computed tomography.
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Neoplasm Grading; Neoplasm Staging; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2020 |
Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of 18F-FDG PET/CT in patients with renal carcinoma: A protocol for systematic review and meta analysis.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Meta-Analysis as Topic; Positron Emission Tomography Computed Tomography; Prognosis; Systematic Review as Topic | 2020 |
FDG-PET/CT imaging during the Covid-19 emergency: a southern Italian perspective.
Topics: Betacoronavirus; Carcinoma; Coronavirus Infections; COVID-19; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Italy; Laryngeal Neoplasms; Pandemics; Pneumonia, Viral; Positron Emission Tomography Computed Tomography; Procedures and Techniques Utilization; Radiopharmaceuticals; Retrospective Studies; SARS-CoV-2; Thymoma | 2020 |
Accuracy of peritoneal carcinomatosis extent diagnosis by initial FDG PET CT in epithelial ovarian cancer: A multicentre study of the FRANCOGYN research group.
Topics: Adult; Aged; Aged, 80 and over; CA-125 Antigen; Carcinoma; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; France; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate | 2020 |
CORR Insights®: Does PET/CT Aid in Detecting Primary Carcinoma in Patients with Skeletal Metastases of Unknown Primary?
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2020 |
A rare case of cranial and spinal leptomeningeal dissemination of recurrent ethmoid carcinoma detected by [18F]-FDG PET/CT.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Topics: Carcinoma; Endopeptidases; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gelatinases; Humans; Image-Guided Biopsy; Male; Membrane Proteins; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Serine Endopeptidases; Stomach Neoplasms | 2020 |
[18F]-FDG PET/CT in a case of metastatic extrahepatic bile duct cancer from sigmoid carcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Carcinoma; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Value of 18F-FDG PET/CT in patients with hepatic metastatic carcinoma of unknown primary.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2020 |
Are there imaging characteristics that can distinguish separate primary lung carcinomas from intrapulmonary metastases using next-generation sequencing as a gold standard?
Topics: Aged; Carcinoma; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; High-Throughput Nucleotide Sequencing; Humans; Lung; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Breast Metastasis of Primary Peritoneal Carcinoma Demonstrated on FDG PET/CT.
Topics: Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Validation of
Topics: Adult; Aged; Carcinoma; Diffusion Magnetic Resonance Imaging; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Pilot Projects; Positron-Emission Tomography; Reproducibility of Results; Survival Analysis; Tomography, X-Ray Computed | 2021 |
Intercostal Brown Adipose Tissue on FDG PET/CT.
Topics: Adipose Tissue, Brown; Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Ribs | 2021 |
Prognostic value of PET parameters in patients with pleomorphic lung cancer: Results from a single institution.
Topics: Carcinoma; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2021 |
Characterizing Concomitant Follicular Lymphoma and Gastric Carcinoma Using 68Ga-FAPI-04 and 18F-FDG PET/CT.
Topics: Aged; Carcinoma; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
Role of FDG PET/CT for detection of primary tumor in patients with extracervical metastases from carcinoma of unknown primary.
Topics: Aged; Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2021 |
Sigmoid Colon Carcinoma Presenting in Inguinoscrotal Hernia With FDG PET/CT.
Topics: Aged; Carcinoma; Colon, Sigmoid; Fluorodeoxyglucose F18; Hernia, Inguinal; Humans; Male; Positron Emission Tomography Computed Tomography | 2022 |
A 77-Year-Old Man with a Pulse Granuloma of the Descending Colon Identified by Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) Imaging 19 Months Following Surgical Resection for Rectal Carcinoma.
Topics: Aged; Carcinoma; Colon, Descending; Fluorodeoxyglucose F18; Granuloma; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms | 2021 |
Higher breast cancer conspicuity on dbPET compared to WB-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2017 |
PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2017 |
Increased FDG uptake on late-treatment PET in non-tumour-affected oesophagus is prognostic for pathological complete response and disease recurrence in patients undergoing neoadjuvant radiochemotherapy.
Topics: Carcinoma; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Coexistence of Mediastinal Castleman Disease with Spindle Cell Carcinoma of the Lung.
Topics: Aged; Carcinoma; Castleman Disease; Chemotherapy, Adjuvant; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mediastinal Diseases; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thoracic Surgical Procedures; Tomography, X-Ray Computed | 2017 |
Prognostic value of primary gross tumor volume and standardized uptake value of
Topics: Adult; Aged; Carcinoma; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Tomography, X-Ray Computed; Tumor Burden | 2017 |
Groin sentinel node biopsy and
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Inguinal Canal; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Minimally Invasive Surgical Procedures; Neoplasm Invasiveness; Neoplasm Staging; Patient Selection; Pilot Projects; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Period; Prospective Studies; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Vulvar Neoplasms | 2017 |
Comparison of
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2018 |
Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Nomograms; Positron Emission Tomography Computed Tomography; Prognosis; Reproducibility of Results; Retrospective Studies; Young Adult | 2017 |
Endoscopic and histopathological analysis of incidental focal colorectal
Topics: Adenoma; Aged; Aged, 80 and over; Carcinoma; Colonoscopy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Melanoma; Middle Aged; Positron Emission Tomography Computed Tomography; Precancerous Conditions; Radiopharmaceuticals; Retrospective Studies | 2018 |
Endobronchial epithelial-myoepithelial carcinoma of the lung.
Topics: Aged, 80 and over; Bronchial Neoplasms; Bronchoscopy; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiography, Thoracic; Radiopharmaceuticals | 2018 |
Significant value of
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neck; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiotherapy, Intensity-Modulated; ROC Curve; Treatment Outcome; Young Adult | 2017 |
Metastasis to the Sellar/Suprasellar Region in a Patient With Endometrial Carcinoma Detected by 18F-FDG PET/CT.
Topics: Aged; Carcinoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Prominent Pulmonary Metastases Without Concurrent Intra-abdominal Metastasis in a Case of Ovarian Carcinoma.
Topics: Abdominal Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Robustness versus disease differentiation when varying parameter settings in radiomics features: application to nasopharyngeal PET/CT.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nasopharyngitis; Positron Emission Tomography Computed Tomography; Radiometry; ROC Curve; Young Adult | 2018 |
Reasons Associated with Total Thyroidectomy as Initial Surgical Management of an Indeterminate Thyroid Nodule.
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Hypothyroidism; Male; Middle Aged; Neoplasms, Multiple Primary; Patient Selection; Positron-Emission Tomography; Retrospective Studies; Thyroid Nodule; Thyroidectomy | 2018 |
[Multiple primary malignant neoplasms detected by PET/CT in cancer patients].
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Cross-Sectional Studies; Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Young Adult | 2017 |
IgG4-Related Disease Simulating Carcinoma Colon With Diffuse Peritoneal Carcinomatosis on 18F-FDG PET/CT.
Topics: Adult; Autoimmune Diseases; Carcinoma; Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Male; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Lymph Node With the Highest FDG Uptake Predicts Distant Metastasis-Free Survival in Patients With Locally Advanced Nasopharyngeal Carcinoma.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Survival Analysis | 2018 |
Prognostic Value of FDG-PET/CT Metabolic Parameters in Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2018 |
Diffuse Liver Metastasis From Nasopharyngeal Carcinoma Found by 18F-FDG PET/CT Scans.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography | 2018 |
Thoracoscopic Resection of Fluorodeoxyglucose-Avid Mediastinal Lymph Nodes Associated with Advanced Ovarian Carcinoma.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thoracic Surgery, Video-Assisted; Treatment Outcome | 2019 |
Occurrence of thymic pathology in two families. Is familial screening justified?
Topics: Adult; Aged; Carcinoma; Early Detection of Cancer; Family; Female; Fluorodeoxyglucose F18; Humans; Male; Mass Screening; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thymoma; Thymus Hyperplasia; Thymus Neoplasms | 2018 |
Pretreatment Primary Tumor and Nodal SUVmax Values on 18F-FDG PET/CT Images Predict Prognosis in Patients With Salivary Gland Carcinoma.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Salivary Gland Neoplasms | 2018 |
Utility of FDG PET/CT in the Characterization of Sinonasal Neoplasms: Analysis of Standardized Uptake Value Parameters.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Paranasal Sinus Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2018 |
Is C-11 Methionine PET an alternative to 18-F FDG-PET for identifying recurrent laryngeal cancer after radiotherapy?
Topics: Aged; Carcinoma; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Methionine; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Use of 18F-FDG PET/CT for the Evaluation of Carcinoma Arising From Choledochal Cysts.
Topics: Adult; Carcinoma; Choledochal Cyst; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Poorly Differentiated Primary Carcinoma of the Middle Ear on 18F-FDG PET/CT.
Topics: Adult; Carcinoma; Ear Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Correlation between tumor glucose metabolism and multiparametric functional MRI (IVIM and R2*) metrics in cervical carcinoma: Evidence from integrated
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A | 2019 |
18F FDG Uptake Due to Late-Onset Osteoradionecrosis for Tongue Base Carcinoma.
Topics: Aged; Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Osteoradionecrosis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tongue Neoplasms | 2019 |
Cholesterol Granuloma Masquerading as Gallbladder Carcinoma on 18F-FDG PET/CT.
Topics: Aged; Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Granuloma; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
18F-FDG PET/CT in Urachal Abscess.
Topics: Abscess; Carcinoma; Child; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Urinary Bladder Neoplasms; Urinary Tract Infections | 2019 |
Challenges in the treatment of parathyroid carcinoma: a case report.
Topics: Adult; Bone Neoplasms; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hyperparathyroidism, Primary; Jaw Diseases; Neoplasms, Multiple Primary; Osteolysis; Parathyroid Neoplasms; Positron Emission Tomography Computed Tomography; Severity of Illness Index; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2019 |
Prognostic Value of Tumor Heterogeneity and SUVmax of Pretreatment 18F-FDG PET/CT for Salivary Gland Carcinoma With High-Risk Histology.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Salivary Gland Neoplasms | 2019 |
Inflammatory response to the anti PD-L1 drug, atezolizumab, masquerades as breast implant rupture.
Topics: Adrenal Cortex Hormones; Aged; Antibodies, Monoclonal, Humanized; B7-H1 Antigen; Breast; Breast Implants; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Rupture; Urinary Bladder Neoplasms; Urothelium | 2019 |
FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; ROC Curve; Tomography, X-Ray Computed; Triple Negative Breast Neoplasms | 2013 |
Clinicopathologic characteristics of synchronous primary thyroid cancer detected by initial staging 18F-FDG PET-CT examination in patients with underlying malignancy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Child; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Male; Middle Aged; Multimodal Imaging; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Vascular Endothelial Growth Factor A; Young Adult | 2013 |
Application of (18)F-FDG PET/CT imaging in diagnosing bladder tumor metastasis lesions.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2013 |
Unusual muscular metastases from papillary thyroid carcinoma detected by fluorine-18-fluorodeoxyglucose PET/MRI.
Topics: Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2013 |
Molecular subtypes of breast cancer: metabolic correlation with ¹⁸F-FDG PET/CT.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Mammography; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2013 |
¹⁸F-FDG PET/CT imaging versus dynamic contrast-enhanced CT for staging and prognosis of inflammatory breast cancer.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Inflammatory Breast Neoplasms; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Non-FDG-avid primary papillary thyroid carcinoma may not differ from FDG-avid papillary thyroid carcinoma.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Mutation; Neoplasm Recurrence, Local; Positron-Emission Tomography; Proto-Oncogene Proteins B-raf; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
Respiratory-gated ¹⁸F-FDG PET/CT for the diagnosis of liver metastasis.
Topics: Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Respiratory-Gated Imaging Techniques; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Incidental focal colorectal ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Area Under Curve; Carcinoma; Colonoscopy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2013 |
Robustness of intratumour ¹⁸F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma; Data Interpretation, Statistical; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2013 |
Selective application of a test based on risk: using limited resources wisely.
Topics: Carcinoma; DNA, Viral; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Radionuclide Imaging | 2013 |
Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging.
Topics: Carcinoma; DNA, Viral; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed | 2013 |
Evaluation of rare choroid plexus metastasis from papillary thyroid carcinoma with multimodality imaging.
Topics: Carcinoma; Carcinoma, Papillary; Choroid Plexus Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
Usefulness of partial volume effect-corrected F-18 FDG PET/CT for predicting I-131 accumulation in the metastatic lymph nodes of patients with thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2013 |
Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Utility of 18F-FDG PET/CT in supracricoid partial laryngectomy.
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Laryngectomy; Larynx; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Republic of Korea; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
¹⁸F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2014 |
Preoperative fluorine 18 fluorodeoxyglucose tumoral uptake ratio between upper and lower abdomen in primary advanced-stage ovarian cancer.
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed | 2013 |
Prognostic relevance at 5 years of the early monitoring of neoadjuvant chemotherapy using (18)F-FDG PET in luminal HER2-negative breast cancer.
Topics: Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptor, ErbB-2; Treatment Outcome | 2014 |
FDG PET/CT in primary pulmonary lymphoepithelioma-like carcinoma.
Topics: Aged, 80 and over; Carcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
[Differential diagnosis of local tumor recurrence or radionecrosis after stereotactic radiosurgery for treatment of brain metastasis].
Topics: Adult; Brain Neoplasms; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiosurgery | 2014 |
Diagnostic accuracy of ¹⁸F-FDG PET/CT for detection of suspected recurrence in patients with oesophageal carcinoma.
Topics: Adult; Aged; Carcinoma; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Anatomical and functional volume concordance between FDG PET, and T2 and diffusion-weighted MRI for cervical cancer: a hybrid PET/MR study.
Topics: Adult; Aged; Carcinoma; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2014 |
Utility of 18F-FDG PET/CT in follow-up of patients with low-grade serous carcinoma of the ovary.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
A rare case of metastatic clear cell carcinoma of the Müllerian system originating from the peritoneum assessed by 18F-FDG PET/CT.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Asymptomatic solitary cerebral metastasis from papillary carcinoma thyroid: 131I SPECT/CT for accurate staging.
Topics: Asymptomatic Diseases; Brain Neoplasms; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Middle Aged; Multimodal Imaging; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2014 |
PET/MRI and PET/CT in follow-up of head and neck cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Is 18F-FDG PET/CT more reliable than 99mTc-MDP planar bone scintigraphy in detecting bone metastasis in nasopharyngeal carcinoma?
Topics: Adult; Aged; Bone Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Young Adult | 2014 |
Additional value of F-18 FDG PET/CT for initial staging in breast cancer with clinically negative axillary nodes.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Radiopharmaceuticals | 2014 |
Transposed ovary mimicking a peritoneal implant on FDG PET/CT in a patient with carcinoma of the rectum.
Topics: Adult; Carcinoma; Colorectal Neoplasms; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Ovary; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Integrated ¹⁸F-FDG PET/perfusion CT for the monitoring of neoadjuvant chemoradiotherapy in rectal carcinoma: correlation with histopathology.
Topics: Adult; Aged; Carcinoma; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Perfusion Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms | 2014 |
Prognostic significance of novel ¹⁸F-FDG PET/CT defined tumour variables in patients with oesophageal cancer.
Topics: Adult; Aged; Carcinoma; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed | 2014 |
Multi-modality imaging to determine the cellular heterogeneity of nasopharyngeal carcinoma components.
Topics: Animals; Carcinoma; Cell Line, Tumor; Contrast Media; Fluorodeoxyglucose F18; Heterografts; Humans; Mice; Mice, Nude; Microscopy, Confocal; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Radiopharmaceuticals | 2014 |
Renal mucinous tubular and spindle cell carcinoma and 18F-fluorodeoxyglucose-PET/CT findings.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Distant subcutaneous recurrence of a parathyroid carcinoma: abnormal uptakes in the (99m)Tc-sestamibi scan and (18)F-FDG PET/CT imaging.
Topics: Biomarkers; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Parathyroid Hormone; Parathyroid Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
The role of metabolic tumor volume and total lesion glycolysis on ¹⁸F-FDG PET/CT in the prognosis of epithelial ovarian cancer.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Thyroid incidentalomas discovered on positron emission tomography CT scanning - Malignancy rate and significance of standardised uptake values.
Topics: Adenocarcinoma, Follicular; Aged; Carcinoma; Carcinoma, Papillary; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
Topics: Adult; Aged; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity | 2014 |
Primary anorectal melanoma on FDG PET/CT.
Topics: Aged; Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed | 2014 |
FDG PET/CT reveals the primary tumor in a patient with occult breast carcinoma undetected by other modalities.
Topics: Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Evaluation of bone metastases from breast cancer by bone scintigraphy and positron emission tomography/computed tomography imaging.
Topics: Bone Neoplasms; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2014 |
Adding maximum standard uptake value of primary lesion and lymph nodes in 18F-fluorodeoxyglucose PET helps predict distant metastasis in patients with nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2014 |
Colon visualization on (99m)Tc-HDP whole-body bone scan due to sigmoid colon cancer-related enterovesical fistula.
Topics: Aged; Bone and Bones; Carcinoma; Fluorodeoxyglucose F18; Humans; Incidental Findings; Intestinal Fistula; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sigmoid Neoplasms; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Urinary Bladder Fistula; Whole Body Imaging | 2015 |
Imaging spectrum of peritoneal carcinomatosis on FDG PET/CT.
Topics: Adult; Aged; Carcinoma; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Peritoneal Neoplasms; Peritoneum; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2014 |
A pleomorphic carcinoma of the lung producing multiple cytokines and forming a rapidly progressive mass-like opacity.
Topics: Carcinoma; Cytokines; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
CT, MRI, and 18F-FDG PET/CT in a patient with nested stromal epithelial tumor of the liver.
Topics: Carcinoma; Child; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Multiple Pulmonary Nodules; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
FDG PET/CT in evaluation of unusual cutaneous manifestations of breast cancer.
Topics: Aged; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2015 |
Detecting interval metastases and response assessment using 18F-FDG PET/CT after neoadjuvant chemoradiotherapy for esophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
[(18)F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Ovarian Neoplasms; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Whole Body Imaging | 2015 |
Prognostic value of metabolic tumor volume as measured by fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in nasopharyngeal carcinoma.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2014 |
Mediastinal sarcoidosis mimicking lymph malignancy recurrence after anti-neoplastic therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Gastrectomy; Granuloma; Humans; Hysterectomy; Lymphatic Irradiation; Lymphatic Metastasis; Mastectomy, Segmental; Mediastinal Diseases; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Stomach Neoplasms; Tissue Distribution; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
Prognostic impact of 18F-FDG PET/CT staging and of pathological response to neoadjuvant chemotherapy in triple-negative breast cancer.
Topics: Breast Neoplasms; Carcinoma; Drug Therapy; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Detection of non-Hodgkin lymphoma by [¹⁸F]FDG-PET/CT in a patient with differentiated thyroid cancer.
Topics: Adult; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Multimodal Imaging; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2015 |
FDG PET/CT diagnostic criteria may need adjustment based on MRI to estimate the presurgical risk of extrapelvic infiltration in patients with uterine endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
The clinical value of 18F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography for predicting regional lymph node metastasis and non-curative surgery in primary gastric carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Odds Ratio; Peritoneal Neoplasms; Positron-Emission Tomography; Regression Analysis; ROC Curve; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Nasopharyngeal tuberculosis mimicking nasopharyngeal carcinoma on (18)F-FDG PET/CT in a young patient.
Topics: Adult; Carcinoma; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tuberculosis, Laryngeal | 2015 |
Standardized uptake value of ¹⁸F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast cancer beyond tumor burden.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cohort Studies; Decision Support Techniques; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2014 |
Subdiaphragmatic gallstone mimicking hepatic malignancy on FDG PET/CT.
Topics: Aged; Carcinoma; False Positive Reactions; Fluorodeoxyglucose F18; Gallstones; Humans; Liver Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
[Diagnostic value of (18)F-FDG PET/CT for solitary nodular-type bronchoalveolar carcinoma].
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Positron-Emission Tomography; Retrospective Studies; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2015 |
Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; Cell Differentiation; Female; Fluorodeoxyglucose F18; France; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Function Tests; Thyroid Neoplasms; Thyrotropin; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2015 |
Diagnostic accuracy of F-18 FDG PET/CECT vs. CECT for detecting recurrence of periampullary carcinoma and its prognostic significance.
Topics: Bile Duct Neoplasms; Bile Ducts; Carcinoma; Cholangiography; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiographic Image Enhancement; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed | 2015 |
Correlation between (68)Ga-DOTA-NOC PET/CT and (18)F-FDG PET/CT in EBV-positive undifferentiated nasopharyngeal carcinoma.
Topics: Adult; Carcinoma; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
The value of 18F-FDG positron emission tomography/computed tomography on the pre-operative staging and the management of patients with pancreatic carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; China; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies | 2014 |
Peritoneal carcinomatosis in primary ovarian cancer staging: comparison between MDCT, MRI, and 18F-FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multidetector Computed Tomography; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Preoperative risk stratification using metabolic parameters of (18)F-FDG PET/CT in patients with endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Different prognostic values of plasma Epstein-Barr virus DNA and maximal standardized uptake value of 18F-FDG PET/CT for nasopharyngeal carcinoma patients with recurrence.
Topics: Adolescent; Adult; Aged; Carcinoma; Child; DNA, Viral; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2015 |
[18F]-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Value as a Predictor of Adjuvant Chemotherapy Benefits in Patients With Nasopharyngeal Carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiography; Survival Rate | 2015 |
Detection of Widespread Metastasis in a Case of Aggressive Carcinoma Showing Thymuslike Differentiation (CASTLE Disease) Using 18F-FDG PET/CT.
Topics: Adult; Carcinoma; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
NUT Midline Carcinoma in Elderly Patients: Usefulness of 18F-FDG PET/CT for Treatment Assessment.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Testicular Neoplasms; Tomography, X-Ray Computed | 2015 |
A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Queensland; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Thyroid incidentalomas detected on 18F-fluorodeoxyglucose-positron emission tomography/computed tomography: Thyroid Imaging Reporting and Data System (TIRADS) in the diagnosis and management of patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiology Information Systems; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; ROC Curve; Thyroid Nodule; Tomography, X-Ray Computed | 2015 |
[Value of FDG PET-CT associated with pathology in diagnosing residual tumor in patients with nasopharyngeal carcinoma after radiotherapy].
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
18F-FDG PET/CT of Liver Lymphoepithelioma-like Carcinoma.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Biopsy; Carcinoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Myometrium; Neoplasm Invasiveness; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Prognostic Value of (18)F-FDG PET-CT in Nasopharyngeal Carcinoma: Is Dynamic Scanning Helpful?
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiography | 2015 |
Thyroid carcinoma detected by incidental (18)F-FDG uptake in a patient with progressive cerebellar syndrome.
Topics: Carcinoma; Carcinoma, Papillary; Cerebellar Diseases; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Paraneoplastic Cerebellar Degeneration; Positron-Emission Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, Emission-Computed | 2016 |
Prognostic Value of Pretherapeutic Tumor-to-Blood Standardized Uptake Ratio in Patients with Esophageal Carcinoma.
Topics: Aged; Aorta; Carcinoma; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Variability of Gross Tumor Volume in Nasopharyngeal Carcinoma Using 11C-Choline and 18F-FDG PET/CT.
Topics: Carbon Radioisotopes; Carcinoma; Choline; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Preablative Stimulated Thyroglobulin Levels Can Predict Malignant Potential and Therapeutic Responsiveness of Subcentimeter-Sized, 18F-fluorodeoxyglucose-Avid Cervical Lymph Nodes in Patients With Papillary Thyroid Cancer.
Topics: Ablation Techniques; Adolescent; Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; ROC Curve; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Young Adult | 2016 |
Multimodal Imaging of Orthotopic Mouse Model of Endometrial Carcinoma.
Topics: Aged; Animals; Carcinoma; Cell Line, Tumor; Contrast Media; Dideoxynucleosides; Disease Models, Animal; Disease Progression; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Transplantation; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
(68)Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma.
Topics: Adult; Aged; Biomarkers; Biomarkers, Tumor; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prospective Studies; Receptors, Somatostatin | 2016 |
The incidence and sites of Nasopharyngeal carcinoma (NPC) metastases on FDG PET/CT scans.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Incidence; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Singapore; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
Liver and bone metastases from breast cancer: Eovist magnetic resonance and diffusion weighted imaging, 18F-FDG positron emission/computed tomography.
Topics: Adult; Breast Neoplasms; Carcinoma; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Neoplasms; Thoracic Vertebrae; Tomography, X-Ray Computed | 2016 |
Hypometabolic Lateral Recti Due to Bilateral Cranial Nerve VI Palsy.
Topics: Abducens Nerve Diseases; Carcinoma; Carcinoma, Papillary; Esotropia; Fluorodeoxyglucose F18; Humans; Middle Aged; Oculomotor Muscles; Positron-Emission Tomography; Radiopharmaceuticals; Skull Base Neoplasms; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2015 |
SERIAL NECK ULTRASOUND IS MORE LIKELY TO IDENTIFY FALSE-POSITIVE ABNORMALITIES THAN CLINICALLY SIGNIFICANT DISEASE IN LOW-RISK PAPILLARY THYROID CANCER PATIENTS.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Population Surveillance; Retrospective Studies; Risk Factors; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography; Young Adult | 2015 |
Asymptomatic Solitary Metastasis to the Testis From Prostate Carcinoma Detected by FDG PET/CT.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Testicular Neoplasms; Tomography, X-Ray Computed | 2016 |
A new method for segmentation of FDG PET metabolic tumour volume using the peritumoural halo layer and a 10-step colour scale. A study in patients with papillary thyroid carcinoma.
Topics: Adult; Aged; Algorithms; Carcinoma; Carcinoma, Papillary; Color; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Observer Variation; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tumor Burden | 2015 |
18F-FDG PET/CT in differentiating malignant from benign origins of obstructive jaundice.
Topics: Aged; Bile Ducts; Carcinoma; Cholecystitis; Choledocholithiasis; Constriction, Pathologic; Digestive System Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Jaundice, Obstructive; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pancreatitis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Combining plasma Epstein-Barr virus DNA and nodal maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography improved prognostic stratification to predict distant metastasis for locoregionally advanced nasopharyngeal carci
Topics: Carcinoma; Disease Progression; Disease-Free Survival; DNA, Viral; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Viral Load | 2015 |
Relationships between transporter expression and the status of BRAF V600E mutation and F-18 FDG uptake in papillary thyroid carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Glutamic Acid; Humans; Immunohistochemistry; Male; Middle Aged; Mutation, Missense; Positron-Emission Tomography; Proto-Oncogene Proteins B-raf; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, Emission-Computed; Valine; Young Adult | 2016 |
A Clinical Pitfall: Optimal Management of Single Dural-based Metastatic Carcinoma of the Breast Mimicking Meningioma.
Topics: Brain Neoplasms; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningioma; Middle Aged; Positron-Emission Tomography | 2015 |
Relation Between F-18 FDG Uptake of PET/CT and BRAFV600E Mutation in Papillary Thyroid Cancer.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mutation; Neoplasm Staging; Positron-Emission Tomography; Proto-Oncogene Proteins B-raf; Retrospective Studies; Sex Factors; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2015 |
Preoperative Prediction of Cervical Lymph Node Metastasis Using Primary Tumor SUVmax on 18F-FDG PET/CT in Patients with Papillary Thyroid Carcinoma.
Topics: Adult; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Positron-Emission Tomography; Preoperative Period; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2015 |
The Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Chemoradiotherapy; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiation Dosage; Radiopharmaceuticals; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Failure; Tumor Burden; Young Adult | 2016 |
Utility of 18F-FDG PET/CT in the assessment of lymphoepithelioma-like carcinoma.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Recurrence; Treatment Outcome | 2016 |
The impact of FDG-PET/CT in the management of patients with vulvar and vaginal cancer.
Topics: Carcinoma; Disease Management; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Vaginal Neoplasms; Vulvar Neoplasms | 2016 |
Surgical Scar Site Recurrence in Patients With Cervical Cancer on 18F-FDG PET-CT: A Case-Control Study.
Topics: Adult; Aged; Carcinoma; Case-Control Studies; Cicatrix; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Uterine Cervical Neoplasms | 2016 |
Evaluation of Time-Phase Effect on 18F-FDG PET/CT Delineation Methods for Treatment Planning of Nasopharyngeal Carcinoma.
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tumor Burden | 2016 |
Establishment of an integrated model incorporating standardised uptake value and N-classification for predicting metastasis in nasopharyngeal carcinoma.
Topics: Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Models, Theoretical; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2016 |
PSMA Expression in Papillary Thyroid Carcinoma: Opening a New Horizon in Management of Thyroid Cancer?
Topics: Acetates; Antigens, Surface; Brain Neoplasms; Carcinoma; Carcinoma, Papillary; Ethylenediamines; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2016 |
Impact of EUS-FNA for preoperative para-aortic lymph node staging in patients with pancreatobiliary cancer.
Topics: Adult; Aged; Aged, 80 and over; Ampulla of Vater; Aorta; Bile Duct Neoplasms; Carcinoma; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Common Bile Duct Neoplasms; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals | 2016 |
Use of Metabolic Parameters as Prognostic Factors During Concomitant Chemoradiotherapy for Locally Advanced Cervical Cancer.
Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Brachytherapy; Carcinoma; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Rate; Uterine Cervical Neoplasms | 2017 |
Comparison between 18F-FDG PET/MRI and MDCT for the assessment of preoperative staging and resectability of gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma; Data Accuracy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms | 2016 |
IgG4-Related Kidney Disease in a Patient With History of Breast Cancer: Findings on 18F-FDG PET/CT.
Topics: Autoimmune Diseases; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Middle Aged; Nephritis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
18F-FDG PET/CT Osteometabolic Activity in Metastatic Parathyroid Carcinoma.
Topics: Bone Neoplasms; Calcium; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Parathyroid Hormone; Parathyroid Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Prognostic utility of (18)F-FDG PET-CT performed prior to and during primary radiotherapy for nasopharyngeal carcinoma: Index node is a useful prognostic imaging biomarker site.
Topics: Adult; Aged; Biomarkers; Carcinoma; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2016 |
Brain-Only Metastases Seen on FDG PET as First Relapse of Papillary Thyroid Carcinoma Two Years Post-Thyroidectomy.
Topics: Brain Neoplasms; Carcinoma; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy | 2016 |
Metabolic tumour volume of anal carcinoma on (18)FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival.
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Forecasting; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Survival Rate; Tumor Burden | 2016 |
Tumor heterogeneity measured on F-18 fluorodeoxyglucose positron emission tomography/computed tomography combined with plasma Epstein-Barr Virus load predicts prognosis in patients with primary nasopharyngeal carcinoma.
Topics: Carcinoma; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Treatment Outcome; Viral Load | 2017 |
Fluorodeoxyglucose Uptake in Advanced Non-small Cell Lung Cancer With and Without Pulmonary Lymphangitic Carcinomatosis.
Topics: Adult; Aged; Carcinoma; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Tumor Burden | 2016 |
Role of
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma; Diagnosis, Differential; Esthesioneuroblastoma, Olfactory; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Nose; Nose Neoplasms; Paranasal Sinus Neoplasms; Paranasal Sinuses; Pilot Projects; Positron Emission Tomography Computed Tomography | 2017 |
A Case of Focal Bone Marrow Reconversion Mimicking Bone Metastasis: The Value of 111Indium Chloride.
Topics: Aged; Bone Marrow; Bone Marrow Neoplasms; Carcinoma; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Indium; Male; Positron Emission Tomography Computed Tomography; Tomography, Emission-Computed, Single-Photon | 2016 |
Extensive Metastases on 18F-FDG PET/CT in Primary Lymphoepithelioma-Like Carcinoma of the Ovary.
Topics: Bone Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Middle Aged; Omentum; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
18F-FDG PET/CT Imaging of Cauda Equina Syndrome Secondary to Leptomeningeal Metastatic Breast Cancer.
Topics: Adult; Breast Neoplasms; Carcinoma; Cauda Equina; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Meningeal Neoplasms; Polyradiculopathy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
68Ga-NODAGA-RGDyK PET/CT Imaging in Esophageal Cancer: First-in-Human Imaging.
Topics: Adult; Carcinoma; Coordination Complexes; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Male; Neovascularization, Pathologic; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Value of
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue.
Topics: Adult; Aged; Carcinoma; Carcinoma, Ovarian Epithelial; Cytoreduction Surgical Procedures; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2016 |
(18)F-fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; ROC Curve; Stomach Neoplasms; Young Adult | 2016 |
Efficacy of qualitative response assessment interpretation criteria at 18F-FDG PET-CT for predicting outcome in locally advanced cervical carcinoma treated with chemoradiotherapy.
Topics: Adult; Aged; Carcinoma; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2017 |
Prognostic value of tumoral heterogeneity and volumetric parameters as measured by F18-FDG PET/CT in sinonasal cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasal Cavity; Neoplasm Recurrence, Local; Nose Neoplasms; Paranasal Sinus Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Tumor Burden | 2017 |
Increased 18F-2-Fluorodeoxysorbitol (18F-FDS) Activity in a Pituitary Spindle Cell Carcinoma.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sorbitol | 2016 |
Clitoral Metastasis From Advanced Cervical Carcinoma on 18F-FDG-PET/CT.
Topics: Carcinoma; Clitoris; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms; Vulvar Neoplasms | 2017 |
Hybrid imaging for detection of carcinoma of unknown primary: A preliminary comparison trial of whole-body PET/MRI versus PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Whole Body Imaging | 2016 |
The intensity of 18FDG uptake does not predict tumor growth in patients with metastatic differentiated thyroid cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2017 |
18F-FDG PET/CT in Metastatic Pilomatrix Carcinoma.
Topics: Aged; Carcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms | 2016 |
18F-FDG PET/CT Features of Chronic Sclerosing Sialadenitis Presenting as Localized IgG4-Related Disease.
Topics: Aged; Autoimmune Diseases; Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Male; Mandibular Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sialadenitis; Submandibular Gland | 2017 |
18F-FDG PET/CT Versus Contrast-Enhanced CT for Staging and Prognostic Prediction in Patients With Salivary Gland Carcinomas.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Salivary Gland Neoplasms; Tomography, X-Ray Computed; Tumor Burden | 2017 |
PET/CT for differentiating between tuberculous peritonitis and peritoneal carcinomatosis: The parietal peritoneum.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Peritoneal Neoplasms; Peritoneum; Peritonitis, Tuberculous; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2017 |
Cytological evaluation by fine needle aspiration biopsy of incidental focal increased fluorodeoxyglucose uptake in thyroid on positron emission tomography scan.
Topics: Adenoma; Adult; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Nodule | 2017 |
Prognostic value of preoperative 18F-FDG PET/CT in papillary thyroid cancer patients with a high metastatic lymph node ratio: a multicenter retrospective cohort study.
Topics: Adolescent; Adult; Aged; Biological Transport; Carcinoma; Carcinoma, Papillary; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Young Adult | 2017 |
18-F-fluorodeoxyglucose-positron emission tomography evaluation of early metabolic response during radiation therapy for cervical cancer.
Topics: Adult; Aged; Brachytherapy; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Metabolism; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Radioisotopes; Regression Analysis; Uterine Cervical Neoplasms | 2008 |
Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2008 |
The added benefit of a dedicated neck F-18 FDG PET-CT imaging protocol in patients with suspected recurrent differentiated thyroid carcinoma.
Topics: Carcinoma; Cell Differentiation; Contrast Media; DNA; Fluorodeoxyglucose F18; Humans; Neck; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Evaluation of the therapeutic effects and recurrence for head and neck cancer after chemoradiotherapy by FDG-PET.
Topics: Adolescent; Adult; Aged; Carcinoma; Child; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2009 |
18F-FDG PET in the management of patients with anaplastic thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color | 2008 |
Intermittent FDG uptake in lipomatous hypertrophy of the interatrial septum on serial PET/CT scans.
Topics: Aged; Carcinoma; Cardiomegaly; Diagnosis, Differential; Esophageal Neoplasms; Fluorodeoxyglucose F18; Heart Septum; Humans; Lipoma; Male; Neoplasm Staging; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed | 2008 |
(18)F-FDG-PET/CT findings of granulocyte colony stimulating factor (G-CSF)-producing lung tumors.
Topics: Adenocarcinoma; Aged; Bone Marrow; Carcinoma; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Granulocytes; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
FDG-PET demonstration of asymptomatic skeletal muscle metastasis from colorectal carcinoma.
Topics: Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
18F-fluorodeoxyglucose uptake in different histological subtypes of nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Nasopharynx; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; World Health Organization; Young Adult | 2009 |
Adrenal tuberculosis revealed by FDG PET.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenal Insufficiency; Adrenalectomy; Aged; Carcinoma; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Tomography, X-Ray Computed; Tuberculosis, Endocrine | 2008 |
18F-FDG PET/CT evaluation of patients with ovarian carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Contribution of 18F-fluorodeoxyglucose positron emission tomography to the diagnosis of early pancreatic carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Chi-Square Distribution; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Treatment Outcome | 2008 |
F18-fluorodeoxyglucose-positron emission tomography for diagnosis of pelvic tuberculosis mimicking peritoneal carcinomatosis.
Topics: Aged; Ascites; CA-125 Antigen; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Peritoneal Neoplasms; Peritonitis, Tuberculous; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2009 |
[A case of solitary splenic metastasis following operation for pulmonary pleomorphic carcinoma: detected at an early stage by FDG-PET].
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Splenic Neoplasms | 2008 |
Use of single MRI and 18F-FDG PET-CT scans in both diagnosis and radiotherapy treatment planning in patients with head and neck cancer: advantage on target volume and critical organ delineation.
Topics: Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms; Parotid Gland; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2009 |
Serendipitous detection of urothelial carcinoma with F-18 FDG PET/CT: usefulness of low intensity PET window setting in areas of high physiologic FDG distribution.
Topics: Aged; Carcinoma; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Positron-Emission Tomography; Tissue Distribution; Tomography, X-Ray Computed; Urothelium | 2009 |
Cancer-associated stroma affects FDG uptake in experimental carcinomas. Implications for FDG-PET delineation of radiotherapy target.
Topics: Animals; Carcinoma; Cell Line, Tumor; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Homozygote; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Mice; Mice, Nude; Neoplasms; Platelet Endothelial Cell Adhesion Molecule-1; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2009 |
Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer.
Topics: Adult; Aged; Aorta; Aortography; Carcinoma; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed; Uterine Neoplasms | 2009 |
Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2009 |
(18)F-FDG PET for the evaluation of thymic epithelial tumors: Correlation with the World Health Organization classification in addition to dual-time-point imaging.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Thymus Neoplasms; Time Factors; World Health Organization | 2009 |
Evaluation of response: is 18F-FDG PET the answer?
Topics: Carcinoma; Diagnostic Imaging; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Medical Oncology; Positron-Emission Tomography; Research Design | 2009 |
The segmental distribution and clinical significance of colorectal fluorodeoxyglucose uptake incidentally detected on PET-CT.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Carcinoma; Colon; Colonic Neoplasms; Colonic Polyps; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2009 |
Fluorodeoxyglucose-positron emission tomography differentiating thrombus from tumor in the left ventricle.
Topics: Bronchial Neoplasms; Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Heart Diseases; Heart Neoplasms; Heart Ventricles; Humans; Positron-Emission Tomography; Thrombosis | 2009 |
[A case of lung cancer producing granulocyte colony-stimulating factor with a significantly high uptake in the bones observed by a FDG-PET scan].
Topics: Bone and Bones; Carcinoma; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography | 2009 |
18F- FDG-PET/CT for the diagnosis of tumor thrombosis.
Topics: Adult; Aged; Carcinoma; Cohort Studies; Diagnosis, Differential; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphoma; Male; Middle Aged; Neoplastic Cells, Circulating; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Thromboembolism; Tomography, X-Ray Computed | 2009 |
Role of PET/CT in the detection of liver metastases from colorectal cancer.
Topics: Aged; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2009 |
Prognostic importance of standardized uptake value on F-18 fluorodeoxyglucose-positron emission tomography in biliary tract carcinoma.
Topics: Aged; Aged, 80 and over; Biliary Tract Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Sex Factors | 2009 |
Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma with a false-positive result on fluorodeoxyglucose PET.
Topics: Aged; Carcinoma; Cholecystitis; False Positive Reactions; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2009 |
Peritoneal carcinomatosis from ovarian cancer: the role of CT and [¹⁸F]FDG-PET/CT.
Topics: Aged; Carcinoma; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2010 |
Adrenocortical tumor with two distinct elements revealed by combined (18)F-fluorodeoxyglucose positron emission tomography and (131)I nor-cholesterol scintigraphy.
Topics: Adenoma; Adosterol; Adrenal Cortex Neoplasms; Aged; Carcinoma; Cushing Syndrome; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2009 |
Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Retrospective Studies; ROC Curve; Sample Size; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Nasopharyngeal carcinoma: relationship between 18F-FDG PET-CT maximum standardized uptake value, metabolic tumour volume and total lesion glycolysis and TNM classification.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
FDG PET/CT in assessment of pulmonary lymphangitic carcinomatosis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iopamidol; Lung Neoplasms; Lymphangitis; Male; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sensitivity and Specificity | 2010 |
Remnant pancreatectomy for recurrent or metachronous pancreatic carcinoma detected by FDG-PET: two case reports.
Topics: Aged; Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Neoplasm, Residual; Neoplasms, Second Primary; Pancreatectomy; Pancreatic Neoplasms; Radionuclide Imaging | 2010 |
High incidence of thyroid cancer in focal thyroid incidentaloma detected by 18F-fluorodeoxyglucose [corrected] positron emission tomography in relatively young healthy subjects: results of 3-year follow-up.
Topics: Adult; Age Factors; Biopsy, Fine-Needle; Carcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Health; Humans; Incidence; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Time Factors | 2010 |
Circulating procalcitonin in aseptic carcinoma patients: a specificity study with (18)F-fluorodeoxyglucose positron-emission tomography/computed tomography as benchmark.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Calcitonin; Calcitonin Gene-Related Peptide; Carcinoma; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Protein Precursors; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
False-positive (18)F-fluorodeoxyglucose positron emission tomography/computed tomography caused by incidental injury in a bulky intracystic carcinoma of the breast.
Topics: Aged, 80 and over; Breast; Breast Neoplasms; Carcinoma; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Foreign-Body Reaction; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Impact of positron emission tomography/computed tomography in the management of patients with epithelial ovarian carcinoma after treatment.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Thymus Neoplasms | 2010 |
Usefulness of interim FDG-PET after induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck receiving sequential induction chemotherapy followed by concurrent chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Combinations; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Squamous Cell; Oxonic Acid; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Remission Induction; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tegafur; Treatment Outcome | 2011 |
Follicular variant of papillary thyroid carcinoma presenting as a toxic nodule by I-123 scintigraphy.
Topics: Carcinoma; Carcinoma, Papillary; Carcinoma, Papillary, Follicular; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed | 2010 |
Diagnostic accuracy of ultrasound and 18-F-FDG PET or PET/CT for patients with suspected recurrent papillary thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Carcinoma, Papillary; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color; Young Adult | 2010 |
Nasopharyngeal carcinoma with splenic and cystic liver metastases in a pediatric patient: 18F-FDG PET-CT findings.
Topics: Adolescent; Carcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Splenic Neoplasms; Tomography, X-Ray Computed | 2010 |
Epithelial-myoepithelial carcinoma of the parotid gland: correlation of dynamic magnetic resonance imaging, (18)F-fluorodeoxyglucose-positron emission tomography, and pathological findings.
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Myoepithelioma; Parotid Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Incidental carcinomas detected by PET/CT scans in patients with malignant lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Incidence; Incidental Findings; Lymphoma; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2010 |
Localization of metastatic parathyroid carcinoma by 18F FDG PET scanning.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Parathyroid Neoplasms; Radionuclide Imaging | 2010 |
Renal metastases from thyroid carcinoma.
Topics: Adenoma, Oxyphilic; Carcinoma; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Kidney Neoplasms; Positron-Emission Tomography; Quality of Life; Thyroid Neoplasms | 2010 |
Incidental finding of F-18 FDG skin uptake in a patient with psoriasis during the evaluation of a recurrent papillary thyroid carcinoma.
Topics: Carcinoma; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Psoriasis; Recurrence; Skin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
Brain metastasis in lung cancer. Comparison of cerebral MRI and 18F-FDG-PET/CT for diagnosis in the initial staging.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Germany; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Subacute trismus in a kidney transplant recipient.
Topics: Aged; Carcinoma; Diagnosis, Differential; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Immunocompromised Host; Kidney Transplantation; Male; Masseter Muscle; Muscle Neoplasms; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Trismus | 2010 |
MRI and PET/CT of patients with bone metastases from breast carcinoma.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mammography; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Evaluation of an intraperitoneal ovarian cancer syngeneic mouse model using 18F-FDG MicroPET imaging.
Topics: Animals; Carcinoma; Female; Fluorodeoxyglucose F18; Injections, Intraperitoneal; Mice; Mice, Inbred C57BL; Models, Animal; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
FDG PET and PET/CT for colorectal cancer.
Topics: Carcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed | 2011 |
PET and PET/CT in the management of thyroid cancer.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms | 2011 |
Lymphoscintigraphy in breast cancer patients after neoadjuvant chemotherapy. Diagnostic value and the work-up of sentinel node negative patients.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2011 |
Detection and characterization of tumor changes in 18F-FDG PET patient monitoring using parametric imaging.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2011 |
[The accuracy of FDG-PET/CT in early-stage cervical and vaginal cancers].
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Uterine Cervical Neoplasms; Vaginal Neoplasms; Young Adult | 2011 |
Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Diagnosis, Differential; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Reference Values; Retrospective Studies; Thymus Neoplasms; Tomography, X-Ray Computed | 2011 |
False-positive positron emission tomography in patients with history of malignancy.
Topics: Adult; Anus Neoplasms; Biopsy; Breast Neoplasms; Carcinoma; Carcinoma, Lobular; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granular Cell Tumor; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Medical Oncology; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Skin Neoplasms; Tomography, X-Ray Computed | 2011 |
Prevalence and significance of thyroid uptake detected by ¹⁸F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Cross-Sectional Studies; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Goiter, Nodular; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Retrospective Studies; Taiwan; Thyroid Gland; Thyroid Neoplasms; Tissue Distribution; Tomography, X-Ray Computed | 2011 |
Clinical applications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of unknown primary.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiography; Reproducibility of Results | 2011 |
Relationship between clinicopathological factors and fluorine-18-fluorodeoxyglucose uptake in patients with papillary thyroid cancer.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transport Proteins, Facilitative; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Young Adult | 2011 |
Diffuse intraabdominal fibrosis and inflammation mimicking peritoneal carcinomatosis recurred after surgery for borderline ovarian tumor misdiagnosed by 18F-fluorodeoxyglucose-positron emission tomography.
Topics: Adenocarcinoma, Mucinous; Adult; Carcinoma; Diagnosis, Differential; Diagnostic Errors; Female; Fibrosis; Fluorodeoxyglucose F18; Humans; Inflammation; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Recurrence | 2011 |
Simultaneous uptake of I-131 and F-18 FDG by a renal metastasis of thyroid papillary cancer.
Topics: Aged; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Kidney Neoplasms; Radionuclide Imaging; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2011 |
Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification.
Topics: Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Treatment Outcome; Tumor Burden | 2011 |
Clinical value of integrated [18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the preoperative assessment of papillary thyroid carcinoma: comparison with sonography.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2011 |
Surgical management of radiation-induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: report of 14 cases.
Topics: Adrenal Cortex Hormones; Adult; Anesthesia; Carcinoma; Fluorodeoxyglucose F18; Follow-Up Studies; Headache; Humans; Intracranial Hypertension; Magnetic Resonance Imaging; Male; Memory Disorders; Middle Aged; Multimodal Imaging; Nasopharyngeal Neoplasms; Necrosis; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Retrospective Studies; Temporal Lobe; Tomography, X-Ray Computed; Vertigo | 2011 |
Intramedullary spinal cord metastasis from papillary thyroid carcinoma.
Topics: Adult; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Laminectomy; Leg; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Cord Neoplasms; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome; Walking; Whole Body Imaging | 2011 |
[Value of (18)F-FDG dual head coincidence imaging in predicting the efficacy of radioiodine therapy for papillary thyroid carcinoma with cervical lymph node metastasis].
Topics: Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Neck; Radionuclide Imaging; Thyroid Cancer, Papillary; Thyroid Neoplasms; Treatment Outcome; Whole Body Imaging | 2011 |
Prognostic impact of standardized uptake value of F-18 FDG PET/CT in nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Reference Standards; Tomography, X-Ray Computed | 2011 |
Radiologic features of NUT midline carcinoma in an adolescent.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Diagnosis, Differential; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Male; Mediastinal Neoplasms; Multimodal Imaging; Neoplasm Proteins; Nuclear Proteins; Oncogene Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Lower neck neurilemmoma can masquerade as lymph node metastasis on FDG PET/CT in patient with nasopharyngeal carcinoma.
Topics: Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neurilemmoma; Positron-Emission Tomography; Tomography, X-Ray Computed; Ultrasonography | 2011 |
Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma; Chemoradiotherapy; Deoxycytidine; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Characterization of adrenal metastatic cancer using FDG PET/CT.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Aged; Carcinoma; China; Cohort Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Hyperplasia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Role of [(18)F]-fluorodeoxy-D-glucose positron emission tomography and computed tomography in the early detection of persistent/recurrent thyroid carcinoma in intermediate-to-high risk patients following initial radioactive iodine ablation therapy.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2012 |
A new brain positron emission tomography scanner with semiconductor detectors for target volume delineation and radiotherapy treatment planning in patients with nasopharyngeal carcinoma.
Topics: Adult; Aged; Bismuth; Brain; Carcinoma; Female; Fluorodeoxyglucose F18; Germanium; Humans; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Predictive value of positron emission tomography-computed tomography image fusion in the diagnosis of head and neck cancer: does it really improve staging and management?
Topics: Biopsy; Carcinoma; Clinical Competence; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Differential diagnosis of primary nasopharyngeal lymphoma and nasopharyngeal carcinoma focusing on CT, MRI, and PET/CT.
Topics: Adolescent; Adult; Aged; Carcinoma; Child; Contrast Media; Cross-Sectional Studies; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
The method and efficacy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for diagnosing the lymphatic metastasis of colorectal carcinoma.
Topics: Adult; Aged; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
Can the pathology of a thyroid nodule be determined by positron emission tomography uptake?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Cohort Studies; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Thyroid Nodule; Young Adult | 2012 |
Diffuse pulmonary metastases with negative ¹⁸FDG positron emission tomography/computed tomography and positive post-radioiodine therapy scan of papillary thyroid cancer.
Topics: Adult; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Multimodal Imaging; Positron-Emission Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
[Laparoscopic para-aortic lymphadenectomy in advanced cervical cancer: morbidity and impact on therapy].
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2012 |
Circulating EBV DNA and ¹⁸F-FDG PET scan in the diagnosis and monitoring of nasopharyngeal carcinoma.
Topics: Carcinoma; DNA, Viral; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Isolated cardiac metastasis from papillary thyroid cancer: prolonged survival with late diagnosis related to inadequate positron emission tomography preparation.
Topics: Carcinoma; Carcinoma, Papillary; Delayed Diagnosis; Female; Fluorodeoxyglucose F18; Heart; Heart Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Survival; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy | 2012 |
Correlations between SUVmax and expression of GLUT1 and growth factors inducing lymphangiogenesis.
Topics: Aged; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Intercellular Signaling Peptides and Proteins; Lymphangiogenesis; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
Clinical value of whole body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of metastatic bladder cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Small Cell; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2012 |
Prediction of central lymph node metastasis from papillary thyroid microcarcinoma by 18F-fluorodeoxyglucose PET/CT and ultrasonography.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Tumor Burden; Ultrasonography | 2012 |
Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI.
Topics: Carcinoma; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Unknown Primary; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Urologic Neoplasms | 2012 |
Factors associated with positive F-18 flurodeoxyglucose positron emission tomography before thyroidectomy in patients with papillary thyroid carcinoma.
Topics: Adult; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Ultrasonography | 2012 |
High FDG and low FLT uptake in a thyroid papillary carcinoma incidentally discovered by FDG PET/CT.
Topics: Biological Transport; Carcinoma; Carcinoma, Papillary; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Detection of intraluminal tracheal metastasis of thyroid papillary carcinoma by 18F-FDG PET/CT.
Topics: Aged; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Tracheal Neoplasms | 2012 |
[The role of PET-CT in detecting unknown primary tumour in patients with cervical lymph node metastases].
Topics: Adult; Aged; Carcinoma; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Male; Melanoma; Middle Aged; Multimodal Imaging; Neck; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
(64)Cu-ATSM and (18)FDG PET uptake and (64)Cu-ATSM autoradiography in spontaneous canine tumors: comparison with pimonidazole hypoxia immunohistochemistry.
Topics: Animals; Autoradiography; Carcinoma; Cell Hypoxia; Coordination Complexes; Copper Radioisotopes; Dogs; Fluorodeoxyglucose F18; Immunohistochemistry; Nitroimidazoles; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Thiosemicarbazones | 2012 |
Nasopharyngeal carcinoma: investigation of intratumoral heterogeneity with FDG PET/CT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Cell Differentiation; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Young Adult | 2012 |
Impact of FDG-PET computed tomography for surgery of recurrent or persistent differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reoperation; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2012 |
Comparison of 18F-fluorodeoxyglucose uptake with the expressions of glucose transporter type 1 and Na+/I- symporter in patients with untreated papillary thyroid carcinoma.
Topics: Adult; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Symporters; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
18F-FDG PET/CT demonstration of a liver metastasis in a patient with papillary thyroid cancer.
Topics: Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy.
Topics: Adult; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Detecting peritoneal dissemination of ovarian cancer in mice by DWIBS.
Topics: Animals; Carcinoma; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Motion; Ovarian Neoplasms; Peritoneal Neoplasms; Peritoneum; Positron-Emission Tomography; Respiration; X-Ray Microtomography | 2013 |
[Efficiency comparison between PET/CT and conventional work-up for evaluating distant metastasis of nasopharyngeal carcinoma].
Topics: Aged; Carcinoma; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2012 |
The role of 18F-FDG PET/CT metabolic tumour volume in predicting survival in patients with metastatic nasopharyngeal carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; DNA, Viral; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Forecasting; Herpesvirus 4, Human; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk Factors; Sex Factors; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Viral Load | 2013 |
Effectiveness of [(124)I]-PET/CT and [(18)F]-FDG-PET/CT for localizing recurrence in patients with differentiated thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neck; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Recurrence; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Ultrasonography; Whole Body Imaging | 2012 |
Increasing the yield of recombinant thyroid-stimulating hormone-stimulated 2-(18-fluoride)-flu-2-deoxy-D-glucose positron emission tomography-CT in patients with differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Recombinant Proteins; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin Alfa; Tomography, X-Ray Computed; Young Adult | 2012 |
Fluorodeoxyglucose-positron emission tomography scan-positive recurrent papillary thyroid cancer and the prognosis and implications for surgical management.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Axillary lymph node metastasis of papillary thyroid carcinoma detected by FDG PET/CT in a thyroglobulin-positive patient with negative whole-body 131I scan.
Topics: Carcinoma; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Metastatic human papillomavirus-positive nasopharyngeal carcinoma with an unusual pattern of aggressive hematogenous spread.
Topics: Alphapapillomavirus; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biomarkers, Tumor; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Diagnosis, Differential; Drug Administration Schedule; Fatal Outcome; Fluorodeoxyglucose F18; Fluorouracil; Heart Failure; Humans; Hypertension, Pulmonary; Hypoxia; Immunohistochemistry; Laryngoscopy; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Papillomavirus Infections; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Randomized Controlled Trials as Topic; Thrombophilia; Tomography, X-Ray Computed; Vascular Neoplasms | 2012 |
[Value of (18)F-FDG PET/CT in the diagnosis of laryngeal carcinoma].
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
[Peritoneal carcinomatosis from ovarian cancer: role of 18F-FDG-PET/CT and CA125].
Topics: Adult; Aged; Aged, 80 and over; CA-125 Antigen; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Integrated peripheral boost in preoperative radiotherapy for the locally most advanced non-resectable rectal cancer patients.
Topics: Aged; Carcinoma; Chemoradiotherapy; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Positron-Emission Tomography; Preoperative Period; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Rectal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2013 |
Subcutaneous and intramuscular metastases of cervix cancer detected with ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography after the chemoradiation therapy.
Topics: Carcinoma; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Subcutaneous Tissue; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2013 |
Evaluation of early response to concomitant chemoradiotherapy by interim 18F-FDG PET/CT imaging in patients with locally advanced oesophageal carcinomas.
Topics: Adult; Aged; Carcinoma; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Predicting tumour response to chemoradiotherapy in oesophageal cancer by early interim 18F-FDG PET: where do we stand and where should we go?
Topics: Carcinoma; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Endometrial carcinoma diagnosed by positron emission tomography: a case report.
Topics: Aged; Carcinoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasms, Multiple Primary; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 2002 |
FDG positron emission tomography to manage patients with an occult primary carcinoma and metastasis outside the cervical lymph nodes.
Topics: Blue Cross Blue Shield Insurance Plans; Carcinoma; Device Approval; Fluorodeoxyglucose F18; Humans; Insurance Coverage; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Neoplasms, Unknown Primary; Outcome Assessment, Health Care; Radiopharmaceuticals; Sensitivity and Specificity; Technology Assessment, Biomedical; Tomography, Emission-Computed; United States; United States Food and Drug Administration | 2002 |
Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
Topics: Adenocarcinoma; Carcinoma; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy.
Topics: Adult; Aged; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Carcinoma; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Treatment Outcome | 2002 |
[Synovial metastases from colonic cancer presenting as arthritis of the knee. Characterization by 18FDG PET scan].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Arthritis; Carcinoma; Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Knee Joint; Male; Synovial Membrane; Tomography, Emission-Computed | 2002 |
[Positron emission tomography for the preoperative staging of esophageal carcinoma].
Topics: Carcinoma; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
How high can the standardized uptake value be?
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Reference Standards; Thyroid Neoplasms; Tissue Distribution; Urinary Bladder Neoplasms | 2002 |
[18 F-fluorodeoxyglucose positron emission tomography for characterization and initial staging of pancreatic tumors].
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Clinical impact of (18)F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative (131)I scanning results after therapy.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed | 2002 |
The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Combined positron emission tomography/computed tomography imaging of recurrent thyroid cancer.
Topics: Adult; Aged; Calcitonin; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Posttherapy surveillance monitoring of cervical cancer by FDG-PET.
Topics: Adenocarcinoma; Carcinoma; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multivariate Analysis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
Detection of early recurrence with 18F-FDG PET in patients with cervical cancer.
Topics: Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
Evaluation of 18F-FDG PET with bladder irrigation in patients with uterine and ovarian tumors.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Radiopharmaceuticals; Therapeutic Irrigation; Tomography, Emission-Computed; Urinary Bladder; Uterine Cervical Neoplasms; Uterine Neoplasms | 2003 |
Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area.
Topics: Adenoma; Adult; Aged; Austria; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Goiter, Endemic; Humans; Male; Middle Aged; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Thyroid Neoplasms; Thyroid Nodule; Tomography, Emission-Computed | 2003 |
Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Mesothelioma; Middle Aged; Neoplasm Staging; New York; Pleural Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Statistics as Topic; Thoracic Cavity; Thoracic Surgical Procedures; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
[18F]Fluorodeoxyglucose positron emission tomography surveillance of hepatic metastases from prostate cancer following radiofrequency ablation: a case report.
Topics: Carcinoma; Catheter Ablation; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Peritoneal carcinomatosis: role of (18)F-FDG PET.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Carcinoma; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Mesothelial; Ovarian Neoplasms; Peritoneal Neoplasms; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms | 2003 |
Peritoneal tuberculosis revealed by carcinomatosis on CT scan and uptake at FDG-PET.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Pelvic Neoplasms; Peritonitis, Tuberculous; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
PET scan evaluation of thymic mass after autologous peripheral blood stem-cell transplantation in an adult with non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Peripheral Blood Stem Cell Transplantation; Radiopharmaceuticals; Thymus Hyperplasia; Tomography, Emission-Computed; Transplantation, Autologous | 2003 |
Diagnostic management of suspected metastatic thyroid carcinoma: clinical value of octreotide scintigraphy in patients with negative high-dose radioiodine scans.
Topics: Adult; Aged; Biopsy, Fine-Needle; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Iodine Radioisotopes; Male; Middle Aged; Octreotide; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed; Whole-Body Counting | 2004 |
Use of FDG-microPET for detection of small nodules in a rabbit model of pulmonary metastatic cancer.
Topics: Animals; Carcinoma; Cell Line, Tumor; Disease Models, Animal; Fluorodeoxyglucose F18; Lung Neoplasms; Rabbits; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2004 |
Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis.
Topics: Adenocarcinoma; Adult; Aged; Antibody Specificity; Autoantibodies; Autoimmune Diseases of the Nervous System; Carcinoma; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Neuroblastoma; Neurons; Ovarian Neoplasms; Paraneoplastic Polyneuropathy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2004 |
Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Prognosis; Radiopharmaceuticals; Risk Factors; Survival Rate; Tomography, Emission-Computed | 2004 |
A problem in diagnosing N3 disease using FDG-PET in patients with lung cancer--high false positive rate with visual assessment.
Topics: Aged; Carcinoma; Diagnostic Errors; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2004 |
[Interest of PET/CT scan fusion to assess mandible involvement in oral cavity and oro pharyngeal carcinomas].
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Mandibular Neoplasms; Middle Aged; Mouth; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Detection of stomach peritoneal infiltration in colorectal cancer using PET-FDG.
Topics: Aged; Carcinoma; Colorectal Neoplasms; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Invasiveness; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2005 |
The utility of multimodality imaging in anaplastic thyroid carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiography, Thoracic; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2004 |
Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Treatment Outcome; Whole-Body Counting | 2005 |
Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2005 |
Detection of thyroid malignancy in a hot nodule by fluorine-18-fluorodeoxyglucose positron emission tomography.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2005 |
FDG-PET evaluation of vaginal carcinoma.
Topics: Carcinoma; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Vaginal Neoplasms | 2005 |
Extraordinarily high F-18 FDG uptake caused by radiation necrosis in a patient with nasopharyngeal carcinoma.
Topics: Carcinoma; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Nasopharynx; Necrosis; Neoplasm Recurrence, Local; Radiation Injuries; Radionuclide Imaging; Radiopharmaceuticals | 2005 |
Intracranial collision tumor mimicking an octreotide-SPECT positive and FDG-PET negative meningioma.
Topics: Aged; Brain Neoplasms; Carcinoma; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Meningioma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2005 |
Detection of thyroid carcinoma in wall of a cystic lesion by FDG PET.
Topics: Adult; Carcinoma; Cysts; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Gland; Thyroid Nodule | 2005 |
PET/CT F-18 FDG scan accurately identifies osteoporotic fractures in a patient with known metastatic colorectal cancer.
Topics: Bone Neoplasms; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lumbar Vertebrae; Middle Aged; Osteoporosis; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Fractures; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Effect of diazepam on the efficacy of dual-phase FDG PET imaging.
Topics: Administration, Oral; Carcinoma; Diazepam; Drug Interactions; Fluorodeoxyglucose F18; Glucose Transport Proteins, Facilitative; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2006 |
In-line (18)F-fluorodeoxyglucose positron emission tomography with computed tomography (PET/CT) in patients with carcinoma of the sinus/nasal area and orbit.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Second Primary; Nose Neoplasms; Orbital Neoplasms; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, Spiral Computed; Whole Body Imaging | 2006 |
[18F]fluorodeoxyglucose positron emission tomography is more sensitive than skeletal scintigraphy for detecting bone metastasis in endemic nasopharyngeal carcinoma at initial staging.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Survival Analysis | 2006 |
FDG-PET on irradiated brain tumor: ten years' summary.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Carcinoma; Child; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis | 2006 |
[Contribution of 18-F-FDG PET for detection of head and neck carcinomas with an unknown primary tumor].
Topics: Adult; Aged; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Usefulness of FDG-microPET for early evaluation of therapeutic effects on VX2 rabbit carcinoma.
Topics: Animals; Carcinoma; Fluorodeoxyglucose F18; Hyperthermia, Induced; Neoplasms, Experimental; Positron-Emission Tomography; Prognosis; Rabbits; Radiopharmaceuticals; Radiotherapy; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2006 |
Correlation between hepatic tumor blood flow and glucose utilization in a rabbit liver tumor model.
Topics: Animals; Aorta; Blood Volume; Capillary Permeability; Carcinoma; Cell Line, Tumor; Cineradiography; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Hepatic Artery; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Male; Portal Vein; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Regional Blood Flow; Tomography Scanners, X-Ray Computed; Tomography, X-Ray Computed | 2006 |
Hürthle cell carcinoma with a giant cystic liver metastasis imaged with 18F-labeled fluorodeoxyglucose-positron emission tomography.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymph Nodes; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Monitoring of response to pre-operative chemoradiation in combination with hyperthermia in oesophageal cancer by FDG-PET.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiotherapy; Sensitivity and Specificity; Treatment Outcome | 2006 |
Lymphadenopathy resulting from acute hepatitis C infection mimicking metastatic breast carcinoma on FDG PET/CT.
Topics: Abdomen; Acute Disease; Adult; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hepatitis C; Humans; Lymphatic Diseases; Lymphatic Metastasis; Mastectomy; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Spinal Neoplasms; Spleen; Tamoxifen; Thoracic Vertebrae; Tomography, X-Ray Computed | 2006 |
18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits.
Topics: Animals; Carcinoma; Catheter Ablation; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Inflammation; Lung; Lung Neoplasms; Neoplasm Transplantation; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed | 2006 |
FDG-PET for prediction of survival of patients with metastatic colorectal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Proportional Hazards Models | 2006 |
Paraneoplastic cerebellar degeneration: Yo-expressing tumor revealed after a 5-year follow-up with FDG-PET.
Topics: Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Cerebellum; Disease Progression; Early Diagnosis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Forecasting; Humans; Immunohistochemistry; Lymph Nodes; Middle Aged; Neoplasm Metastasis; Nerve Tissue Proteins; Paraneoplastic Cerebellar Degeneration; Positron-Emission Tomography; Sentinel Lymph Node Biopsy; Time Factors | 2006 |
FDG-PET detected thyroid incidentalomas: need for further investigation?
Topics: Biopsy, Fine-Needle; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2007 |
Pulmonary lymphangitic carcinomatosis (PLC): spectrum of FDG-PET findings.
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Epithelial-myoepithelial carcinoma of the submandibular gland with a high uptake of 18F-FDG: a case report and image diagnosis.
Topics: Aged; Carcinoma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Submandibular Gland Neoplasms; Tomography, Spiral Computed | 2007 |
PET: other thoracic malignancies.
Topics: Carcinoma; Cost-Benefit Analysis; Diagnostic Imaging; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mesothelioma; Neoplasm Staging; Patient Care Planning; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Neoplasms; Thymoma; Thymus Neoplasms | 2006 |
The clinical impact of 18F-FDG PET in papillary thyroid carcinoma with a negative 131I whole body scan: a single-center study of 108 patients.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms; Whole Body Imaging | 2006 |
18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
FDG PET and PET/CT for the detection of the primary tumour in patients with cervical non-squamous cell carcinoma metastasis of an unknown primary.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
FDG-PET in the clinical management of carcinoma of unknown primary with metastatic cervical lymphadenopathy: shifting gears from detecting the primary to planning therapeutic strategies.
Topics: Carcinoma; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neck; Neoplasms, Unknown Primary; Positron-Emission Tomography; Practice Patterns, Physicians'; Radiopharmaceuticals | 2007 |
Should FDG-PET imaging be considered on a routine basis in clinical trials for carcinoma of esophagus to assure uniformity of protocols among sites?
Topics: Carcinoma; Clinical Trials as Topic; Esophageal Neoplasms; Fluorodeoxyglucose F18; Guidelines as Topic; Humans; Positron-Emission Tomography; Quality Assurance, Health Care; Radiography; Radiopharmaceuticals | 2007 |
Tumour thrombus in the superior vena cava from anaplastic carcinoma of the thyroid: FDG-PET/CT imaging findings.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Vena Cava, Superior; Venous Thrombosis; Whole Body Imaging | 2007 |
Comparison of dynamic FDG-microPET study in a rabbit turpentine-induced inflammatory model and in a rabbit VX2 tumor model.
Topics: Animals; Carcinoma; Disease Models, Animal; Fluorodeoxyglucose F18; Inflammation; Neoplasms, Experimental; Positron-Emission Tomography; Rabbits; Turpentine | 2007 |
FDG PET in detecting primary and recurrent malignant salivary gland tumors.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Salivary Gland Neoplasms; Sensitivity and Specificity | 2007 |
Diagnosis of maxillofacial tumor with L-3-[18f]-fluoro-alpha-methyltyrosine (FMT) PET: a comparative study with FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Facial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Jaw Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tyrosine | 2007 |
Blood flow quantification with permeable contrast agents: a valid technique?
Topics: Animals; Aorta; Blood Volume; Capillary Permeability; Carcinoma; Cell Line, Tumor; Cineradiography; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Hepatic Artery; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Male; Portal Vein; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Regional Blood Flow; Tomography Scanners, X-Ray Computed; Tomography, X-Ray Computed | 2007 |
Dural metastases responsible for benign vertebral collapses.
Topics: Adolescent; Carcinoma; Fluorodeoxyglucose F18; Fractures, Spontaneous; Humans; Male; Neoplasm Metastasis; Positron-Emission Tomography; Spinal Fractures; Spinal Neoplasms; Spine; Tomography, Emission-Computed, Single-Photon | 2007 |
Preoperative imaging for metastasectomy.
Topics: Adrenal Gland Neoplasms; Bone Neoplasms; Carcinoma; Colorectal Neoplasms; Contrast Media; Diagnostic Imaging; Digestive System Neoplasms; Enteroendocrine Cells; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Metastasis; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2007 |
Metastasis of the gastrointestinal tract: FDG-PET imaging.
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Metastatic eccrine porocarcinoma detected on FDG PET/CT.
Topics: Carcinoma; Eccrine Glands; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Pelvic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Subtraction Technique; Sweat Gland Neoplasms; Tomography, X-Ray Computed | 2007 |
Incidence of thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive thyroid incidentalomas.
Topics: Adenoma, Oxyphilic; Carcinoma; Fluorodeoxyglucose F18; Humans; Incidence; Incidental Findings; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Whole Body Imaging | 2007 |
FDG-PET in cervical cancer: staging, re-staging and follow-up.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2007 |
Avoidance of misinterpretation of an FDG positive sacral insufficiency fracture using PET/CT scans in a patient with endometrial cancer: a case report.
Topics: Bone Neoplasms; Carcinoma; Diagnosis, Differential; Diagnostic Errors; False Positive Reactions; Female; Fluorodeoxyglucose F18; Fractures, Spontaneous; Fractures, Stress; Humans; Image Enhancement; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sacrum; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
F-18 FDG PET identification of right atrium metastasis from a vesical carcinoma.
Topics: Aged; Carcinoma; Diverticulum; Fluorodeoxyglucose F18; Heart Atria; Heart Neoplasms; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
[Usefulness of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography in diagnosis and treatment of pelvic recurrence of bladder cancer after radical cystectomy: a case report].
Topics: Carcinoma; Cystectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2007 |
Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study.
Topics: Adult; Aged; Carcinoma; Endoscopy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasms; Neoplasms, Unknown Primary; Positron-Emission Tomography; Practice Guidelines as Topic; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Sensitivity and Specificity | 2008 |
Integrated PET/CT of salivary gland type carcinoma of the lung in 12 patients.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Salivary Gland Neoplasms; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed | 2007 |
Epithelial and mesenchymal tumor compartments exhibit in vivo complementary patterns of vascular perfusion and glucose metabolism.
Topics: Animals; Carcinoma; Epithelial Cells; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Glucose; Magnetic Resonance Imaging; Mesoderm; Mice; Positron-Emission Tomography; Rats | 2007 |
Standardized uptake values for breast carcinomas assessed by fluorodeoxyglucose-positron emission tomography correlate with prognostic factors.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2007 |
The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Preoperative diagnosis of lymph node metastases of colorectal cancer by FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Colonic Neoplasms; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Rectal Neoplasms; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Disseminated tuberculosis masquerading as metastatic breast carcinoma on PET-CT.
Topics: Adult; Breast Diseases; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tuberculosis | 2008 |
Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Carcinoma; Diagnosis, Differential; Feasibility Studies; Female; Fluorodeoxyglucose F18; Hamartoma; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Pneumonia; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2008 |
Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biopsy; Carcinoma; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Likelihood Functions; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation.
Topics: Carcinoma; Carcinoma, Squamous Cell; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymph Nodes; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Oropharyngeal Neoplasms; Paranasal Sinus Neoplasms; Prognosis; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1994 |
Preoperative imaging of parathyroid carcinoma by positron emission tomography.
Topics: Adult; Carcinoma; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Parathyroid Neoplasms; Preoperative Care; Sodium Pertechnetate Tc 99m; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1994 |
[Whole body positron emission tomography in breast cancer].
Topics: Adenocarcinoma; Adenofibroma; Adolescent; Adult; Aged; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Prospective Studies; Tomography, Emission-Computed | 1993 |
Recurrent postoperative parathyroid carcinoma: FDG-PET and sestamibi-SPECT findings.
Topics: Aged; Carcinoma; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hyperparathyroidism; Male; Neoplasm Recurrence, Local; Parathyroid Neoplasms; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Whole-body scintigraphy with 99Tcm-MIBI, 18F-FDG and 131I in patients with metastatic thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Aged; Carcinoma; Carcinoma, Papillary; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Radiography; Reproducibility of Results; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Tomography, Emission-Computed | 1997 |
Positron emission tomographic imaging of head and neck lesions.
Topics: Absorption; Adenoma; Aspergillosis; Carcinoma; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Deoxyglucose; Feasibility Studies; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Granuloma; Head and Neck Neoplasms; Histiocytoma, Benign Fibrous; Humans; Magnetic Resonance Imaging; Maxillary Sinus; Maxillary Sinus Neoplasms; Maxillary Sinusitis; Nasopharyngeal Neoplasms; Papilloma; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed; Tongue Neoplasms; Treatment Outcome | 1997 |
Follow-up of sweat gland carcinoma by FDG-PET imaging.
Topics: Carcinoma; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sweat Gland Neoplasms; Tomography, Emission-Computed | 1998 |
Differentiation of cardiac tumor from thrombus by combined MRI and F-18 FDG PET imaging.
Topics: Adult; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Echocardiography; Female; Fluorodeoxyglucose F18; Heart Diseases; Heart Neoplasms; Humans; Magnetic Resonance Imaging; Radiopharmaceuticals; Thrombosis; Tomography, Emission-Computed | 1998 |
Computed tomography, magnetic resonance imaging and positron emission tomography in non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Forecasting; Gastroscopy; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Methionine; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Radiopharmaceuticals; Remission Induction; Stomach Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
18F-labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracil.
Topics: Aged; Antidotes; Antimetabolites, Antineoplastic; Carcinoma; Colorectal Neoplasms; Drug Interactions; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Liver; Liver Neoplasms; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Detection of unknown primary cancer with fluor-deoxy-glucose positron emission tomography.
Topics: Biopsy, Needle; Carcinoma; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Nasopharynx; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
[F-18 FDG PET for detection of occult primary tumor in patients with lymphatic metastases of the neck region].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver.
Topics: Adult; Aged; Carcinoma; Colonic Neoplasms; Contraindications; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Laparotomy; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Patient Care Planning; Radiopharmaceuticals; Rectal Neoplasms; Reoperation; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
[Value of Pet-18FDG in lung cancer].
Topics: Carcinoma; Cost-Benefit Analysis; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 1999 |
Initial evaluation of pulmonary abnormalities: CT-guided fine-needle aspiration biopsy and fluoride-18 fluorodeoxyglucose positron emission tomography correlation.
Topics: Biopsy, Needle; Carcinoma; Carcinoma, Bronchogenic; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Retrospective Studies; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed | 2000 |
Staging an esophageal carcinoma by F-18 fluorodeoxyglucose whole-body positron emission tomography.
Topics: Carcinoma; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Spinal Neoplasms; Thoracic Vertebrae; Tomography, Emission-Computed | 2000 |
Dynamic 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography of liver tumours without blood sampling.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Carcinoma; Carcinoma, Hepatocellular; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma.
Topics: Adult; Aged; Carcinoma; Colonic Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laparotomy; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Prospective Studies; Radiography, Abdominal; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 2000 |
Fluorine-18 FDG positron emission tomography in advanced nasopharyngeal carcinoma.
Topics: Adult; Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Nasopharyngeal Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Comparative efficacy of positron emission tomography and ultrasonography in preoperative evaluation of axillary lymph node metastases in breast cancer.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mastectomy; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Ultrasonography | 2000 |
Comparison of 18-fluoro-2-deoxyglucose positron emission tomography and computed tomography in detection of cervical lymph node metastases of nasopharyngeal carcinoma.
Topics: Adult; Aged; Biopsy; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neck; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Extensive F-18 FDG uptake in metastatic spindle cell carcinoma of the lung.
Topics: Aged; Carcinoma; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Radiopharmaceuticals; Soft Tissue Neoplasms; Thoracic Neoplasms; Tomography, Emission-Computed | 2001 |
Ki-67 immunostaining in pancreatic cancer and chronic active pancreatitis: does in vivo FDG uptake correlate with proliferative activity?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma; Cell Division; Cell Nucleus; Chronic Disease; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Pancreatitis; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
[18F-FDG positron-emission-tomography in cervical carcinoma: preliminary findings].
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2001 |
FDG positron emission tomographic, radioiodine, and MIBI imaging in a patient with poorly differentiated insular thyroid carcinoma.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
Lymph node staging by positron emission tomography in patients with carcinoma of the cervix.
Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Carcinoma; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed; United States; Uterine Cervical Neoplasms | 2001 |
Clinical impact of (18)F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative (131)I scanning results after therapy.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
Leptomeningeal carcinomatosis and intramedullary spinal cord metastases from lung cancer: detection with FDG positron emission tomography.
Topics: Carcinoma; Carcinoma, Large Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Middle Aged; Radiopharmaceuticals; Spinal Cord Neoplasms; Tomography, Emission-Computed; Whole-Body Counting | 2001 |
Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Child; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2001 |
Detection of a recurrent parathyroid carcinoma with FDG positron emission tomography.
Topics: Adult; Calcium; Carcinoma; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hyperparathyroidism; Magnetic Resonance Imaging; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Parathyroid Hormone; Parathyroid Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.
Topics: Adult; Aged; Carcinoma; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Monostotic Paget's Disease of a cervical vertebra: differential diagnosis with F-18 FDG positron emission tomography using a coincidence technique and with Tc-99m dicarboxypropane diphosphonate.
Topics: Aged; Bone Neoplasms; Carcinoma; Cervical Vertebrae; Diagnosis, Differential; Diphosphonates; Fluorodeoxyglucose F18; Humans; Organotechnetium Compounds; Osteitis Deformans; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Tongue Neoplasms | 2002 |
[The role of FDG-PET scan in the diagnosis of pancreatic carcinoma].
Topics: Adult; CA-19-9 Antigen; Carcinoma; Cholangiopancreatography, Endoscopic Retrograde; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2002 |
[Evaluating the effectiveness of chemotherapy in patients with head-neck tumors using positron emission tomography (PET scan)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Glucose; Carcinoma; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Deoxyglucose; Fluorodeoxyglucose F18; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Oropharyngeal Neoplasms; Prospective Studies; Tomography, Emission-Computed | 1992 |
18F-fluorodeoxyglucose imaging in preoperative diagnosis of thyroid malignancy.
Topics: Adenoma; Adult; Aged; Carcinoma; Carcinoma, Papillary; Deoxy Sugars; Deoxyglucose; DNA, Neoplasm; Female; Flow Cytometry; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Ploidies; Radionuclide Imaging; Thyroid Neoplasms | 1988 |